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ABSTRACT

LYMPHOCYTE EGRESS SIGNAL SPHINGOSINE-1-PHOSPHATE PROMOTES ERMGUIDED, BLEB-BASED MIGRATION
Tanner Ford Robertson
Janis K. Burkhardt

Ezrin, radixin, and moesin (ERM) family proteins regulate cytoskeletal responses by
tethering the plasma membrane to the underlying actin cortex. Mutations in ERM
proteins lead to severe combined immunodeficiency, but the function of these proteins in
T cells remains poorly defined. Using mice in which T cells lack all ERM proteins, we
demonstrate a selective role for these proteins in facilitating egress from lymphoid
organs in response to sphingosine-1-phosphate (S1P), a pleiotropic signaling lipid
abundant in the blood and lymph. ERM-deficient T cells display defective S1P-induced
migration in vitro, despite normal responses to standard protein chemokines that control
entry into and migration within lymphoid organs. Analysis of these defects revealed that
S1P promotes a fundamentally different mode of migration than chemokines,
characterized by intracellular pressurization and bleb-based motility. ERM proteins
facilitate this process, controlling directional migration by limiting blebbing to the leading
edge. We propose that the distinct modes of motility induced by S1P and chemokines
are specialized to allow T cell migration across lymphatic barriers and through tissue
stroma, respectively.
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CHAPTER 1: INTRODUCTION
1.1:

Cell Migration and Immunity
From bacteria to mammals, cellular motility is integral to life. Single-cell

organisms rely on motility for the acquisition of nutrients and the evasion of harsh or
toxic environments [1]. In multicellular organisms, motility plays a fundamental role in
development, but most terminally differentiated cells are non-motile [2]. Some cells, like
erythrocytes, move throughout the body passively via blood flow, but do not actively
migrate on their own. In the mature host, cell motility is particularly important for the
hematopoietic compartment, where it plays an indispensable role in immunity. Among
his many observations, Élie Metchnikoff noted that leukocytes not only extravasate into
inflamed tissues, but that this process continues even after the death of the host when
blood flow has ceased – an early indication of leukocytes’ intrinsic migratory capacity [3].
Leukocytes use their special migratory abilities to the survey the host for
infections. Fundamental differences in how myeloid and lymphoid cells detect microbes
has resulted in two complementary but distinct surveillance programs. Innate immune
cells use germline-encoded receptors to detect common microbial products, allowing a
small number of tissue-resident sentinel cells at barrier sites to recognize a wide variety
of pathogenic threats and mobilize circulating myeloid cells to the site of infection en
masse [4, 5]. Generic pathogen recognition is a luxury not afforded to lymphocytes.
Genetic recombination events during lymphocyte development produce a pool of T and
B cells with immense diversity in their antigen receptor specificity [6], but this creates a
separate problem. In an adult mouse, this resulting repertoire contains only ~100 naïve T
cells capable of responding to any given antigen [7, 8]. Since naïve lymphocytes have
1

no way of knowing where their specific or “cognate” antigen may appear, they must
perpetually traffic throughout the host in a process termed homeostatic immune
surveillance. This introductory chapter details this surveillance process first at the
organismal level (trafficking) and then at the cellular and molecular levels (migration).

1.2:

Lymphocyte Surveillance

Naïve T cell Trafficking
The main purpose of T cell homeostatic surveillance is the detection of rare,
cognate antigens. Antigens and antigen-presenting cells (APCs) collect regionally in
lymph nodes and other secondary lymphoid tissues distributed strategically throughout
the host, allowing naïve lymphocytes to sample locally available antigens without
surveying the entirety of the tissue [9]. For T cells, homeostatic immune surveillance
occurs in four discrete steps:
1. Circulating T cells enter into lymph nodes from the blood.
2. T cells migrate intranodally, scanning APCs for cognate antigen in the form of
peptide-MHC complexes.
3. If no cognate antigen is detected, T cells egress from the lymph node via efferent
lymphatic vessels.
4. Lymphatics merge with the vasculature, returning to step 1.

If T cells spend too little time in a given lymph node, they are prone to missing
rare cognate antigen. If T cells linger for too long, they may take unacceptably long to
discover cognate antigen that has collected in a different node. In both cases, the result
is the same: delayed onset of adaptive immunity. These two opposing evolutionary
2

forces have created an extremely efficient process guided by a variety of soluble and
cell-bound migratory cues. Each step in this homeostatic immune pathway is outlined
below.
Lymph Node Entry
Initial entry into lymph nodes from the blood is a highly regulated process.
Lymphocytes in the blood first interact with specialized high endothelial venules (HEVs;
[10]) and gain access to the lymph node through the sequential function of three
receptors: CD62L (L-selectin), C-C Chemokine Receptor Type 7 (CCR7), and
lymphocyte function-associated antigen 1 (LFA-1). HEVs uniquely express a
sulfotransferase that modifies cell surface proteins including CD34, GlyCAM-1, and
MAdCAM-1 with a 6-sulfo sialyl LewisX carbohydrate group [11, 12]. These modified
proteins are collectively referred to as peripheral node addressin (PNAd) and act as the
ligand for CD62L [13]. The interaction between CD62L and PNAd captures circulating
lymphocytes and causes them to begin rolling along the HEV surface [14]. T cell rolling
along the endothelium permits CCR7 to bind to one of its ligands, CCL21, which is
immobilized on the HEV luminal surface through an interaction with cell surface heparan
sulfate [15]. CCR7-dependent signaling then drives LFA-1 from a bent, inactive
conformation to an extended, highly active conformation. Extended LFA-1 binds to HEVexpressed ICAM-1, and this interaction terminates rolling and promotes firm adhesion on
the HEV walls [16]. Deletion or blockade of CD62L, CCR7, or LFA-1 prevents T cells
from entering into lymph nodes, indicating that each homing receptor is necessary [1720]. Along those lines, neutrophils express CD62L and LFA-1 but not CCR7 and are
therefore excluded from lymph nodes under normal conditions [21].

3

In contrast to tethering, rolling, and firm adhesion, the actual process of
transendothelial migration across the HEV or signals that prompt it are poorly
understood. Autotaxin (ATX), an enzyme that converts the ubiquituous blood lipid
lysophosphatidyl choline into lysophosphatidic acid (LPA), is highly expressed at HEVs.
Pharmacological inhibition of ATX abrogates transendothelial passage and results in
lymphocytes accumulating at HEVs, apparently unable to transverse [22]. Likewise, LPA
promotes T cell polarization, motility, and transendothelial migration in vitro [23, 24].
However, T cells express multiple LPA receptors, and HEV cells themselves are
responsive to LPA, which warrants further research into how LPA prompts
transendothelial passage [24]. Along these lines, HEVs are not simple portals into the
lymph nodes, but rather function as trafficking controllers by retaining T cells near the
entry point to regulate T cell abundance in the lymph node parenchyma [25].
Intranodal Migration
Within lymph nodes, various non-hematopoietic cell populations create a
structural network that doubles as a migratory roadway for T, B, and Dendritic Cells [26].
T cells that enter lymph nodes through the HEVs are guided to the paracortex by a
network of fibroblastic reticular cells (FRCs; [27, 28]). These cells highly express the
chemokines CCL19 and CCL21, both ligands for CCR7, in addition to ligands for LFA-1
and a second integrin, very late antigen 4 (VLA-4). T cells migrate directly on these FRC
networks, which restricts migration to the paracortex, where T cells can scan APCs for
cognate peptide-MHC complexes [29]. Deletion of CCR7 or its ligands results in T cell
disorganization, migration defects, and associated immune deficiencies [18, 30].
Although CCR7 plays a major role in lymph node entry, these intranodal migratory
defects are apparent even when HEV entry is bypassed by direct injection of T cells into
4

afferent lymphatics, indicating a clear role for CCR7 in intranodal guidance [31]. Further,
CCR7-deficient T cells are severely disorganized in the spleen, which does not possess
HEVs or utilize CCR7-dependent entry [18].
Follicular dendritic cells (FDCs) and marginal reticular cells (MRCs), two other
non-hematopoietic stromal cell populations, form a corresponding network in the lymph
node follicles. Unlike FRCs, FDCs and MRCs highly express the chemokine CXCL13, a
ligand for the B cell chemokine receptor CXCR5 [32, 33]. CXCR5 thus guides recent B
cell immigrants into the B cell follicle, but follows the same basic principles of migration
guided by non-hematopoietic stromal cell networks as T cell migration to the paracortex
[34]. Naïve T and B cell populations are therefore largely segregated from one another in
secondary lymphoid organs. [34].
Egress
T cells spend approximately 12 hours in a given lymph node searching for
antigen and, if none is found, will leave via the efferent lymphatics [35]. T cells first
egress by passing through lymphatic sinuses present in the lymph node cortex near the
T cell zone. From there, lymphatic flow carries them to macrophage-rich medullary
sinuses, then through the subcapsular space, and ultimately into the efferent lymphatic
vessels [36]. The central signal guiding T cell egress is sphingosine-1-phosphate (S1P),
a pleiotropic signaling lipid present in high concentrations in the blood and lymph, but
maintained in low concentrations in the interstitial fluid of lymphoid organs [37]. This
distribution creates a high-to-low S1P gradient between the circulatory fluids and
lymphoid organs that T cells recognize with S1P receptor 1 (S1PR1, Edg1). Recognition
of this S1P gradient with S1PR1 prompts T cell passage into the lymphatic sinuses from
5

the lymph node parenchyma [38, 39]. While lymph nodes typically exist in series, these
lymphatics ultimately merge with the thoracic duct, which places lymphocytes back into
blood, restarting the successive process of lymph node entry, intranodal migration, and
egress.
Variations in the Spleen
The spleen is the largest secondary lymphoid organ and maintains several
distinctive features compared to lymph nodes that alter how T cells survey the organ.
First, the majority of the splenic parenchyma, termed “red pulp”, is devoted blood
filtration and other immunologically-independent functions [40]. Lymphocytes are
concentrated in discrete regions termed “white pulp” [40]. Unlike lymph nodes, the
spleen has no high endothelial venules. Instead, lymphocytes and antigen alike are
transported into the spleen via the central arteriole, which carries them to the marginal
zone – the demarcation between the red and white pulp [41]. Thus, relative to the lymph
nodes, entry into the spleen is considered a passive process. Once in the splenic
marginal zone, T and B cells segregate in the white pulp based on similar principles as
the lymph nodes. T cells responding to CCL19 and CCL21 segregate from B cells
responding to CXCL12 and CXCL13 [18, 42]. Marginal zone B cells, which are spleenresident and do not recirculate, are the primary APC population in the spleen [43-45].
The route of T cell egress from the spleen has remained ill-defined, but occurs directly
into the vasculature in an S1PR1-dependent fashion [46]
Effector Lymphocyte Trafficking
The majority of naïve T cells never find cognate antigen, but those that do enter a
rapid proliferative phase that coincides with large-scale transcriptional changes [47, 48].
In addition to the acquisition of effector functions, activation results in profound
6

alterations in the expression of various chemoattractant receptors and adhesion
proteins, which endows effector T cells with new surveillance and migratory capabilities.
Shortly after T cell receptor (TCR) stimulation, T cells downregulate S1PR1, which
causes them to remain lymph node resident during their highly proliferative phase [49].
Some effector T cells, especially CD8+ cells, will subsequently re-express S1PR1 to
leave the lymph node and traffic to infected or inflamed peripheral tissues [50]. Entry into
inflamed peripheral tissues by effector T cells is facilitated by the upregulation of VLA-4
and expression of CD44, which bind to VCAM-1 and hyaluronic acid, respectively, both
components of inflamed endothelia [51-53]. Activated T cells also shed CD62L, which
prevents further entry into lymph nodes and thus facilitates peripheral homing [54-56].
T follicular helper (Tfh) cells and germinal center B (GCB) cells remain in the
draining lymph node following activation but alter their expression of chemoattractant
receptors to coordinate germinal center responses. Naïve B cells normally localize to the
follicle by virtue of CXCR5, with signaling through the receptor EBI2 biasing B cells to
the outer perimeter [18, 34, 57]. Following activation, B cells downregulate CXCR5 and
express the T cell chemokine receptor CCR7, which prompts their migration to the
border of the T cell zone or paracortex [58]. At the T cell border, activated B cells interact
with antigen-specific CD4+ T cells to form highly dynamic and mobile cell conjugates
[59]. These B cells then migrate, guided by the receptor EBI2 and its oxysterol ligand, to
the outer regions of the follicle near the subcapsular space (interfollicular zone) where
they proliferate for 1-2 days prior to the formation of a proper germinal center [60-62].
Cognate T cells are also present at this interfollicular zone either through their own EBI2
guidance [63] or by virtue of being dragged there by B cells [59]. Several days postactivation, GCB cells and Tfh cells begin organizing formal germinal centers in the
7

center of the primary follicle. Movement from the interfollicular region to the nascent
germinal center is mediated by the loss of EBI2 and expression of S1PR2 and P2RY8 by
both Tfh and GCB cells. While S1P concentrations are substantially lower in lymphoid
organs than blood or lymph, concentrations are not uniform across the tissue
parenchyma. S1P concentrations are lowest in the center of the follicle, and the same is
likely true for the ligand of P2RY8, S-Geranylgeranyl-L-glutathione [64, 65]. S1PR2 and
P2RY8 simultaneously inhibit lymphocyte migration to chemokines and appear to drive
chemorepulsion away from gradients of S1P or S-Geranylgeranyl-L-glutathione, which
culminates in Tfh and GCB cells tightly clustering in the center of the follicle [65-68].
Light and dark zones subsequently form, and GCB cells use CXCR4 to move into the
dark zones and CXCR5 to move into the light zones [69].
Memory T cell Trafficking
Memory T cells that form after pathogen clearance can be divided into “central
memory” and “effector memory” subsets based on their expression of trafficking proteins
[70]. Central memory T cells retain expression of the critical homeostatic surveillance
receptors CD62L and CCR7 and therefore continue a surveillance program of secondary
lymphoid organs similar to naïve T cells [71]. Effector memory populations downregulate
CCR7 and CD62L, which reduces their capacity to enter peripheral lymph nodes [70,
72]. Effector memory cells primarily survey peripheral non-lymphoid tissue, but can enter
lymph nodes through alternative receptors under some situations [73, 74]. Some
memory T cell populations express tissue-specific homing receptors that allows them to
preferentially survey tissues where a pathogenic threat was initially encountered. For
example, expression of the chemokine receptors CCR4 and CCR10 promote preferential
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trafficking to the skin

[75-77], and expression of the integrin α4β7 along with the

chemokine receptor CCR9 promotes trafficking to the intestines [78-81].
Tissue-resident memory cells are a more recently-described subset that remain
in peripheral tissues with no apparent re-circulation [82]. Tissue-resident memory cells
have been observed in the skin [83, 84], intestines [85], lungs [86], salivary glands [87],
and brain [88]. This tissue residency depends on the sustained suppression of S1PR1
function, which otherwise prompts T cell movement into the circulatory fluids [89, 90].
Further, tissue-resident memory cells upregulate the integrin αEβ7, which is dispensable
for entry into peripheral sites but is crucial for retention, likely by facilitating T cell
interactions with tissue epithelial cells [88, 90-92].
In summary, T cell trafficking is integral to adaptive immunity. Antigen search,
effector function, and memory surveillance are all orchestrated by the local production of
chemoattractants, chemoerepellents, adhesion ligands, and the cell-specific expression
of their various receptors. Protein chemokines and lipid chemoattractants like S1P
appear to play complementary but functionally distinct roles in this trafficking process.
Much of the data presented in this dissertation is devoted to comparing how S1P and
chemokines differentially influence T cell migration, and how that reflects their unique in
vivo functions. We were able to address these questions by developing a cell culture
technique that makes primary mouse T cells responsive to S1P through S1PR1 in vitro,
and utilized this technique to compare and contrast S1PR1 and chemokine receptor
signaling and migratory strategies. With the organismal-level picture of T cell trafficking
now described, this introduction will now focus in on migration at the cellular and
molecular levels.
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1.3

Migration Strategies

In its simplest form, cell migration occurs when a protrusion at one pole of the cell is
coupled to subsequent retraction on the opposite pole. This process results in net
displacement, especially when performed in cycles: protrusion, retraction, protrusion,
retraction, and so on. While this is simple in principle, cells display an incredible amount
of plasticity in how they move. This migratory diversity reflects both the heterogenous
environments cells must migrate through and the biological purpose for their migration.
For instance, straight line “ballistic” migration is ideal for a neutrophil chasing a
pathogen, but impractical for a T cell searching numerous APCs for rare, cognate
antigen. Additionally, cells may need to produce qualitatively different types of
protrusions for crossing endothelial barriers compared to migrating within tissue
parenchyma.
Actin and Myosin
There are two central components that facilitate migration in cells: actin and
myosin. Actin is a small globular protein that can be polymerized into filaments in a
regulated fashion. In resting cells, actin filaments assemble subjacent to the plasma
membrane to form the actin cortex [93]. These actin filaments are cross-linked by
myosin, resulting in a higher order structure referred to as the actomyosin complex or
simply actomyosin. Actomyosin controls fundamental biological properties like cell
shape, membrane tension, and intracellular pressure and is central to all modes of
migration [94-97].
Humans express up to 40 different myosin genes organized into more than 20
distinct classes [98, 99]. All myosins possess an N-terminal catalytic motor domain that
binds to actin [100, 101], but show great diversity in their C-terminal regions. This
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diversity allows myosins to bind cargoes, assemble into filaments, and perform other
functions. Myosin proteins operate by utilizing the energy gained from ATP hydrolysis to
walk along actin filaments [102]. Depending on the myosin isoform and what the Cterminus is interacting with, walking along actin filaments can transport cargo proteins or
cause a cellular contraction [103].
The Myosin II subfamily is the largest group of myosins, and it encompasses the
myosins that carry out the well-known contractile functions in cardiac, skeletal, and
smooth muscle cells as well as three additional members termed non-muscle myosin IIs
(NMIIs) that are expressed more broadly [99]. The C-terminus of myosin II heavy chain
does not bind cargo but instead dimerizes with another myosin II protein in parallel
fashion [104]. Each myosin II heavy chain in this dimer further associates with one
essential light chain (ELC), which provides structural stability, and one regulatory myosin
light chain (MLC), which modulates the activity of the catalytic motor domain [105, 106].
As a whole, this forms a hetero hexamer myosin complex, which further assembles into
bipolar filaments [107]. When these myosin filaments collectively walk along actin, they
cause the actin filaments to slide towards each other. This is an actomyosin contraction.
When myosin is distributed unevenly over the cell cortex, actomyosin contractions can
facilitate unique biological outcomes. Contractile activity at the cleavage furrow, for
instance, mediate cytokinesis [108, 109]. In migratory cells, myosin classically localizes
to the rear and powers trailing edge retractions [110-112].
Non-muscle myosin II shows low levels of activity even in resting cells, which
keeps the plasma membrane under slight tension and creates a heightened intracellular
pressure [97, 113, 114]. This contractile activity is modulated by phosphorylation of the
MLC, especially at the tandem Thr18 and Ser19 positions, which increases the ATPase
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activity of the catalytic head domain [115-117]. These crucial sites are phosphorylated
by Rho-associated protein kinase (ROCK), myosin light-chain kinase (MLCK), or other
kinases to increase actomyosin contractile activity in response to various stimuli [118120].
Protrusions – actin-polymerization vs blebs
Cellular protrusions are typically driven by actin polymerization against the
plasma membrane. The initial polymerization of actin is energetically unfavorable and
must be initiated by a class of proteins called nucleation promoting factors. Depending
on the factors at play, actin can be polymerized into a dense, highly-branched
meshwork, which generates sheet-like protrusions called lamellipodia or it can be
polymerized into parallel linear bundles that generate finger-like projections called
filipodia (Illustrated in Fig. 1.2A-B). Lamellipodia are generated by the Arp2/3 complex,
which binds pre-existing filaments and nucleates a new filament at a 70-degree angle
from the initial filament [121, 122]. Filipodia are generated by the formin family of
proteins, which generate long actin cables by simultaneously promoting polymerization
and blocking filament capping [123-125]. While some cells almost exclusively use
lamellipodia or filipodia, cells frequently utilize a blend, with Arp2/3 contributing to
filipodia formation [126] and formins contributing to lamellipodia formation [127].
Irrespective of the type of actin structure that cells use for their leading-edge protrusions,
myosin plays a key role in trailing edge retraction [110-112].
Blebs are a fundamentally different type of protrusion than those generated by
localized actin polymerization. Blebs occur when intracellular pressure causes the
plasma membrane to herniate from the underlying actin cortex (Illustrated in Fig 1.2C).
Blebs occur in three discrete phases: initiation, expansion, and retraction [128]. Under
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normal conditions, the plasma membrane is tightly associated with the underlying actin
cortex. Bleb initiation occurs when there is a decrease in the membrane-cortex
association, an increase in intracellular pressure, or some combination of the two [129131]. Bleb expansion lasts only a few seconds, during which time the flow of cytosol
causes inflation of the nascent bleb. The protrusion is devoid of actin or other major
cytoskeletal machinery at this stage. Bleb formation is associated with an apparent
increase in cell surface area [132], but lipid membranes can only stretch 2-3% before
rupturing [133]. Bleb expansion thus appears to occur through the localized unfolding of
small lipid invaginations to supply membrane during the expansion phase [134]. The
actin cortex eventually reforms underneath the new protrusion, which ceases expansion
[135, 136]. This reformation occurs sequentially, with ezrin, radixin, and moesin (ERM)
family proteins first localizing the bleb membrane followed by actin, actin-bundling
proteins, then myosin [137]. What promotes actin nucleation at the bleb membrane is
unclear, as Arp2/3 and formins are conspicuously absent from nascent bleb at this time
of cortex repolymerization [137]. Retraction is typically not observed in motile cells, with
new blebs sprouting from old blebs as soon as the cortex has been repolymerized [135].
For blebs to drive productive migration, they must occur in a polarized manner.
One initial study found that the driving force behind blebs – cytoplasmic pressure – could
be unequally distributed throughout the cell, which could theoretically drive polarized
blebbing [138]. Subsequent studies have challenged the notion of unequal cytoplasmic
pressure, or at least its ability to drive polarized blebbing [139, 140]. Polarized blebbing
could also occur under uniform intracellular pressure but localized weaknesses in the
membrane-cortex interaction. Two studies in bleb-prone cancer cell models have shown
that membrane-cortex linker proteins, especially ERM family proteins, accumulate at the
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periphery and rear of migrating cells to limit blebbing outside the leading edge [141,
142]. Defects in bleb-based migration have also been observed in ERM-deficient
zebrafish progenitor cells [143]. Thus, ERM proteins serve dual roles in bleb prevention
and retraction, with the former function playing a critical role in steering bleb-based
motility.
While blebs have long been observed at the leading edge of migratory cells [144147], they have historically been less well-studied than actin-based protrusions [148],
perhaps due to their association with apoptosis [149]. More recent studies showing that
bleb-based migration occurs in vivo during development have quelled any notion that
blebs are somehow artefactual or less physiologically relevant than their actin-based
counterpart [135, 150]. Cells can alternate between actin-based protrusions or blebs
depending on the extracellular environment, with cells preferring actin-rich pseudopods
in two-dimensional settings and preferring blebs in confined settings [151, 152]. Further,
lamellipodia seem optimized for migration on high-adhesion surfaces whereas blebbased motility largely relies on the traction afforded by confinement for net displacement.
While most research on bleb-based motility has focused on non-hematopoietic cells,
lymphocytes also display bleb-based motility in three-dimensional or confined settings
[153]. A crucial open question is whether T cells toggle between actin polymerization
and bleb-based motility for different migratory goals in vivo. Intravital imaging
experiments have shown some indications of T cells using lamellipodia for intranodal
migration and transendothelial migration through the HEVs [27, 154], but the transiency
and protein-dim nature of blebs makes them difficult to study by these methods. Thus, a
role for bleb-based migration in lymphocyte trafficking, if any, remains to be determined.
In this thesis, I identify a role for bleb-based motility in response to S1P but not
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chemokines, which will be covered extensively in the results and discussion portions of
this document.

1.4

Ezrin, Radixin, and Moesin Family Proteins

Discovery and Evolution
Ezrin, radixin, and moesin are the three members of the ERM protein family. Ezrin was
first identified as a component of the brush border of chicken intestinal epithelial cells in
1983 and named after Ezra Cornell, the founder of Cornell University [155]. This was
followed up by the identification of moesin in bovine uterus smooth muscle cells [156]
and radixin from rat hepatocytes [157, 158]. Moesin is an acronym for membraneorganizing extension spike protein, and radixin, first identified as a component of
adherens junctions was named after radix, the Latin word for “root” or “foundation”.
Ezrin, radixin, and moesin are highly homologous at the amino acid level (~85% in mice
and humans) and are generally considered to be functionally overlapping if not simply
redundant when co-expressed in a cell [159-161]. Most cells express multiple ERM
family members [162], and deletions of individual members typically only cause overt
phenotypes in cells or tissues where that isoform is exclusively expressed. Radixin, for
instance, is uniquely expressed in the cochlear stereocilia, and global deletion results in
progressive auditory loss in mice with limited phenotypes observed in other tissues
[163].
A single ERM ortholog most closely related to moesin is common in nonvertebrates

including

fruit

flies

(Drosophila

melanogaster;

[164]),

nematodes

(Caenorhabditis elegans; [165, 166]), and tunicates (Ciona intestinalis; [167]). Ezrin and
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radixin are suspected to have arisen from gene duplication events in a common ancestor
to vertebrate animals [168, 169]. While most vertebrates encode ezrin, radixin, and
moesin in their genomes, several animals, especially birds and fish, deviate from these
norms. For instance, Atlantic Salmon (Salmo salar) harbor ten ERM genes (2 ezrin, 4
radixin, and 4 moesin), and complete loss of the moesin gene is observed in many
species of birds [169] .
Structure, Function, and Regulation
The primary function of ERM family proteins is to link the plasma membrane to
the underlying actin cortex in a regulatable manner. All ERM proteins have an
approximately 300 amino acid N-terminal FERM (4.1 protein, ezrin, radixin, moesin)
domain that binds to the membrane phosphatidyl inositol (PtdIns) lipid PtdIns(4,5)P2
(PIP2) at the inner leaflet of the plasma membrane, an approximately 200 amino acid
intermediary region, and an approximately 100 amino acid C-terminal region (CERMAD) that contains an actin-binding domain (ABD; Fig. 1.3a; [170-172]). By
simultaneously binding to the membrane and the actin cortex, ERM proteins are able to
tether these two structures together (Fig. 1.3b).
ERM proteins are conformationally regulated, existing in either inactive or active
forms. The inactive form occurs through a head-to-tail intramolecular interaction that
masks both the membrane and actin binding sites (Fig. 1.3b [173, 174]). ERM proteins
undergo a two-step transition into the active conformation. First, an initial interaction with
PIP2 causes a slight conformational change that unmasks a critical threonine residue
(Thr558 for moesin) in the ABD [175-177]. Second, phosphorylation of this threonine
residue destabilizes the interaction between the FERM and ABD domains, driving a
conformational change into the active, open state where the protein can simultaneously
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bind the

membrane and actin

[178-180]. The PIP2 binding and threonine

phosphorylation occur sequentially, with both being critical for ERM linker function [175,
181]. Replacing this critical threonine residue with aspartate creates a phospho-mimetic
mutant that is constitutively active. Overexpression of this mutant generates aberrant
actin-dependent membrane structures like microvilli and often interferes with cellular
functions [182-185]. In the open conformation, the FERM domain is also reported to bind
to numerous protein binding partners at the plasma membrane to help organize and
regulate signaling events [186].
Various kinases are reported to phosphorylate the regulatory threonine residue in
the ABD including PKCα [187], PKCθ [188], ROCK [178, 182, 189], NIK [190], LOK [191,
192], and several others [193]. Many of these kinases act in a context-specific manner,
enabling specialized functions of ERM proteins across different tissues. The most
compelling evidence for the relevant ERM kinase in lymphocytes is for LOK
(lymphocyte-oriented kinase, STK10). In the absence of LOK, cells from the spleen,
lymph nodes, and bone marrow all display substantial reductions (~80%) in resting ERM
phosphorylation levels along with altered migratory responses [191]. On the other end,
both myosin phosphatase and protein phosphatase 1α (PP1α) have been reported to
dephosphorylate ERM proteins at the regulatory threonine residue [194-197]. The
dynamic regulation of ERM protein activity through dephosphorylation/rephosphorylation
is critical to several biological processes. For example, during cell division, broad ERM
phosphorylation first promotes cell rounding and spindle alignment and subsequent
dephosphorylation selectively at the poles facilitates cytokinesis [198-202].
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The Role of ERM Proteins in Epithelial Cells
ERM proteins are also regulated by subcellular localization. In a variety of tissue
and cell types, phosphatidyl inositol kinases, phosphatases, and lipases coordinate to
form asymmetrical distributions of PtdIns species variably phosphorylated on their
inositol ring [203-207]. In tubular organs, PIP2 is concentrated in the apical membranes
of epithelial cells and absent from basolateral regions, whereas PtdIns(3,4,5)P3 (PIP3)
shows the opposite distribution [205, 206]. Through their interaction with PIP2, ERM
proteins are commonly localized to the apical membranes where they play crucial roles
in maintaining actin-dependent structures. Ezrin, for instance, localizes to apical domain
of intestinal epithelial layers and controls villus morphogenesis. In the absence of ezrin,
mice die perinatally due to defective nutrient absorption secondary to issues with their
brush border organization [208]. The sole ERM protein in Drosophila plays a similar role
in maintaining epithelial polarity during development [209].
The Role of ERM proteins in Leukocytes
As in epithelial morphogenesis and maintenance, phosphatidylinositol species
display a polarized distribution in migratory cells. From amoebas to leukocytes, PI3K and
PTEN coordinate to concentrate PIP3 at the leading edge and PIP2 at the periphery and
rear of polarized, migrating cells [203, 210-212]. Just like PIP2, ERM proteins localize to
the periphery and rear of migratory amoebas [213], neutrophils [214], lymphocytes [215],
and various cell lines [142]. However, the role of ERM proteins in cell migration has
remained enigmatic.
Lymphocytes express high levels of moesin, moderate amount of ezrin, and
negligible amounts of radixin [216, 217]. Chemokine stimulation in both T and B cells
drives rapid ERM dephosphorylation lasting between 10-60 minutes [184, 217, 218]. The
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fraction of ERM proteins that remain phosphorylated following chemokine stimulation
localize to the uropod, a specialized membrane structure in the rear of polarized
lymphocytes [215, 219]. The importance of the remaining pool of active ERM proteins, if
any, is unclear as ERM-deficient T cells can chemotax normally in most scenarios [220].
Several groups have investigated a role for ERM proteins in lymphocyte
polarization or the formation of uropod structures, often yielding conflicting results.
Stephen Shaw’s group reported that expression of a phospho-mimetic moesin (T558D)
potently interfered with chemokine-induced T cell polarization [184], whereas Martinelli
et al. reported that expression of an analogous phospho-mimetic ezrin (T567D) led to
excessive T cell polarization, even in the absence of chemokine [221]. This discrepancy
doesn’t appear to be an ezrin vs moesin difference, as the Shaw group later reported
that transgenic expression of phospho-mimetic ezrin (T567E) also blocked T cell
polarization and potently interfered with migratory responses [185]. Martinelli et al.
reported that a dominant negative version of ezrin blocked chemokine-induced
polarization, but these data must be interpreted with caution since this construct has the
potential to interfere with any PIP2-binding protein or PIP2-dependent process [221].
Using ezrin-knockout, moesin-knockdown (ERM-deficient) T cell blasts, Chen et al.
found that ERM proteins were important for uropod formation in response to β1, but not
β2 integrin engagement [220]. These data indicate that ERM proteins are not required
for polarization per se, but may facilitate it under some conditions. Likewise, ERMdeficient neutrophils stimulated with the chemokine CXCL1 show only mild polarization
defects [222].
Irrespective of these context-dependent alterations in uropod formation or
polarization, ERM proteins are largely dispensable for actual migratory responses under
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most circumstances. ERM-deficient T cells chemotax normally in transwell assays and
migrate normally in collagen gel matrices [220]. When the pore size in the transwell is
reduced from 5-microns to 3-microns, ERM-deficient T cells do show consistent
migratory defects, likely indicating a preferential need for ERM proteins in confined
settings [220].
While much of the in vitro work on the migration of ERM-deficient T cells shows
underwhelming phenotypes, there is compelling in vivo data from both mice and humans
that these proteins play a critical role in lymphocyte trafficking. First, mice with a
germline deletion in moesin were originally reported to be phenotypically normal [223],
but closer analysis revealed these mice are lymphopenic due to a cell-intrinsic
lymphocyte egress defect [224]. How moesin facilitates egress remains unclear. Second,
hemizygous missense mutations in moesin cause severe combined immunodeficiency
(SCID) in humans, with patient T cells showing potent migratory defects in vitro [225].
This disease, termed X-linked moesin-associated immunodeficiency (X-MAID), is
characterized clinically by profound lymphopenia, moderate neutropenia, poor vaccine
responses, and recurrent bacterial and viral infections [225]. Six out of the seven
patients described in this initial cohort have the same hemizygous missense R171W
mutation in the moesin FERM domain, but the effect of this mutation on moesin function
is still unknown. Since 2016, four additional SCID patients with this same R171W
mutation have been identified by newborn screens or whole exome sequencing [226228].
In addition to their role in lymphocyte trafficking, ERM proteins also appear to
carry out additional, often disparate, functions in lymphocytes. Although B cells express
high levels of moesin, loss of ezrin alone results in augmented B cell receptor (BCR)
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signaling and dysregulated humoral immune responses. Ezrin-deficient B cells display
enlarged BCR microclusters at the membrane following stimulation and exhibit a
corresponding increase in downstream signaling [229]. This effect is not recapitulated in
ezrin-deficient T cells, which show modest diminution of TCR signaling and associated
defects in cytokine production and activation [217]. In T cells, ezrin and moesin localize
to the posterior region during immunological synapse formation, forming a membrane
domain termed the distal pole complex. In this way, they are proposed to promote T cell
activation by sequestering several negative regulators of TCR signaling [217, 230].
Finally, moesin has been implicated in maintaining CD8+ regulatory T cells by regulating
IL-15-mediated signaling, and moesin-deficient T cells develop lupus erythematosus-like
autoimmune phenotype with age [231].

1.5

Sphingosine-1-Phosphate (S1P) and S1P Receptors

Regulation of S1P concentrations
Sphingosine-1-Phosphate (S1P) is a pleiotropic signaling lipid, and its
concentrations in various tissues are tightly regulated. S1P is produced during normal
sphingolipid metabolism and is therefore found in low concentrations in virtually all cells
[232-234]. The transportation of intracellularly-generated S1P into the extracellular
space, however, is highly specialized. S1P is most abundant in the circulatory fluids, and
different cellular sources contribute S1P to the blood and lymph. In blood, extracellular
S1P is produced by the hematopoietic compartment, with erythrocytes being the primary
contributor [235]. Platelets also store large amounts of S1P that is released upon
stimulation [236, 237], but platelet-derived S1P doesn’t appear to contribute to the
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homeostatic serum or lymph S1P levels critical for egress [235, 238]. Both erythrocytes
and platelets utilize the transporter Mfsd2b for S1P secretion. Deletion of Mfsd2b
reduces serum S1P concentrations by approximately 50%, resulting in mild lymphopenia
[239]. Additional S1P transporters in erythrocytes are suspected but not yet identified.
Lymphatic endothelial cells (LECs) are the major supplier of extracellular S1P to
the lymph and are thus critical for egress from the lymph nodes [240]. LECs utilize the
S1P transporter Spns2, and its deletion ablates virtually all lymph S1P [241]. The
contribution of Spns2 to blood S1P is contested, with different groups reporting mild to
severe reductions in serum S1P concentrations in the absence of the transporter [241243].
Many biological functions depend not just on the presence of S1P but on the
high-to-low concentration gradient that exists between the circulatory fluids and tissues,
including lymphoid organs. S1P is irreversibly degraded into phosphoethanolamine and
hexadecenal by S1P lyase, an intracellular enzyme located in the endoplasmic reticulum
and mitochondria of various cells [244]. Pharmacologically inhibiting or genetically
reducing S1P lyase activity creates a uniformly high S1P environment between lymphoid
organs and circulatory fluids, and potently interferes with lymphocyte egress [37, 245].
S1P lyase is abundantly expressed by non-hematopoietic cells, but deletion in these cell
lineages has no apparent impact on S1P concentrations in the interstitial fluid of
lymphoid organs. Instead, the egress-relevant S1P lyase activity is restricted largely to
CD11c+ dendritic cells that are positioned near egress sites [246].
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S1P receptors in lymphocytes
Both mice and humans express five dedicated G protein-coupled receptors
(GPCRs) for S1P (S1PR1-5). Naïve T cells express high levels of S1PR1 (Edg1), and
deletion of this receptor severely reduces egress from primary and secondary lymphoid
organs in a T cell-intrinsic manner [38, 39]. Within the lymph node, CCR7 and S1PR1
act as competing retention and egress signals, respectively [247]. T cells limit the
influence of S1PR1 in this balancing act through ligand-induced endocytosis. Cells in the
S1P-rich circulatory fluids endocytose S1PR1, diminishing their attraction to blood or
lymph and permitting their subsequent entry lymphoid organs [248]. Within the S1P-poor
environment of the lymph node, T cells progressively upregulate surface S1PR1,
restoring their sensitivity to S1P egress signals. In addition to controlling responsiveness
to S1P, ligand-induced endocytosis also plays an important role in proper signaling
through S1PR1 [249]. While ligand-induced endocytosis is crucial for homeostatic
trafficking of naïve T cells, the lymph node retention of recently activated T cells is
controlled by other mechanisms. Following T cell receptor recognition of cognate
peptide-MHC or interferon signaling, T cells upregulate CD69, which interacts with
S1PR1 on the plasma membrane and prompts its internalization [49]. Activation-induced
S1PR1 downregulation is transient, and effector T cells eventually utilize S1PR1 to leave
the lymph node, enter the blood, and access infected or inflamed peripheral tissues [50].
Memory T cells display different trafficking patterns than their naïve counterparts
including the ability to survey non-lymphoid tissues [250, 251]. Tissue-resident memory
T cells embed themselves in peripheral tissues and stop recirculating, a process that
depends on the loss of S1PR1 expression [89].
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While most research on S1PR1 in lymphocytes has focused on its role in
trafficking, the importance of S1PR1 is not limited to egress. The periodic burst of
S1PR1 signaling that occurs during egress is also critical for maintenance of
mitochondrial content and long-term survival of naïve lymphocytes [252]. S1P signaling
through S1PR1 limits proliferation of common lymphoid progenitor cells to regulate
lymphopoiesis [253]. Two- to three-fold overexpression of S1PR1 in T cells in vivo
simultaneously inhibits the formation of regulatory T cells while promoting Th1
differentiation [254]. Given that S1PR1 signaling appears to modulate T cell
differentiation, it is worth exploring whether S1P concentrations change in draining
lymph nodes or circulatory fluids during different kinds of pathogenic challenges.
In addition to S1PR1, naïve T cells express high levels of S1PR4, but the impact
of S1PR4 on naïve CD4+ T cell trafficking is still subject to debate [255]. The weak
phenotypes observed following loss of S1PR4 are somewhat surprising because unlike
all other S1P receptors, S1PR4 is exclusively expressed in the hematopoietic
compartment under normal conditions. One recent study found that S1PR4 does appear
to synergize with S1PR1 for effector and memory T cells in peripheral tissues to gain
access to draining lymphatics [256], but the role for S1PR4 in naïve T cell homeostatic
surveillance is still unclear.
Various S1P receptors play critical roles in the function of other lymphocyte
populations. S1PR5 is highly expressed by mature natural killer cells and controls their
egress from the bone marrow into the blood [257, 258], playing a similar role as S1PR1
does for T cells. S1PR3 is highly expressed by marginal zone B cells and functions
alongside S1PR1 and CXCR5 to control Marginal Zone (MZ) B cell shuttling between the
follicle and marginal zone in the spleen [45, 259].
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S1PR2 is distinct from the other S1P receptors. Poorly expressed in naïve
lymphocytes, S1PR2 is strongly upregulated in GCB cells and Tfh cells [64, 67]. In both
cell populations, S1PR2 promotes clustering in the germinal center where Tfh and GCB
cells coordinate to produce high-affinity antibodies. In addition to controlling localization,
S1PR2 limits the proliferation and signaling of GC B cells, and extreme outgrowths of
these cell populations in chronically-established germinal centers occur in about half of
S1PR2-deficient mice [64]. Whereas S1PR1, 3, 4, and 5 all promote chemotaxis in
various lymphocyte populations in transwell assays, S1PR2 does not [39, 45, 256, 257].
On the contrary, when S1P is sensed through S1PR2 it can impede migration to
chemokines or induce chemorepulsion on its own [64, 260]. Thus, while S1PR1, 3, 4, 5
drive either egress or migration in response to S1P, S1PR2 appears to limit motility to
control organization and positioning within lymphoid organs [261].
S1PR1 function in non-lymphocytes
S1PR1 plays critical roles in non-lymphocytes, especially during development.
Global deletion or knockdown of S1PR1 results in severe developmental defects in both
mice and zebrafish due to impaired vascular development and associated edema [262264]. During vascularization, S1PR1 acts in a cell-intrinsic manner to promote mature
blood vessel formation by antagonizing VEGF-driven angiogenic sprouting [265]. S1PR1
is also crucial to platelet production, and conditional deletion of S1PR1 in
megakaryocytes results in severe thrombocytopenia. In these cells, S1PR1 responding
to S1P gradients guides megakaryocyte proplatelet extensions into bone marrow
sinusoids to permit platelet release [266]. How a single ligand-receptor pair drives such
disparate biological outcomes in different cell types remains a fascinating question.
Interestingly, ligand-induced S1PR1 endocytosis occurs quickly in lymphocytes but
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slowly in endothelia following S1P exposure [267]. S1PR1 has been shown to exhibit
sustained signaling from endosomes in some contexts [268], which creates the
possibility that cells may derive different outcomes from S1PR1 ligation by shunting the
receptor to different subcellular localizations where it may engage in different signaling
pathways. While this has not demonstrated for S1PR1, internalization-dependent
signaling events have been demonstrated for other GPCRs [269].
S1PR1 structure and ligand binding
Due to its lipid nature, S1P also binds to its receptors in an atypical fashion. Like
all GPCRs, S1PR1 possesses a seven-pass transmembrane region, but the extracellular
region normally involved in ligand binding is occluded by an N-terminal helical region in
the crystal structure [270]. There is an abnormally large gap between helices I and VII in
the transmembrane region, however, and S1P is thought to access the binding pocket
by first integrating into the outer leaflet of the plasma membrane and then diffusing
laterally into this pocket [270-272]. This method of ligation explains why S1P shows such
slow saturation of S1PR1 binding sites and how S1P within the endosomal membrane
can activate S1P receptors [273, 274].
One additional layer of complexity for S1P is the very nature of peptide/protein vs
lipid chemoattractants. While chemokines like CCL19 are readily soluble in aqueous
solutions of the body, lipids like S1P are not. S1P is transported by binding noncovalently to carrier proteins, with the primary partners being Apolipoprotein M (ApoM),
the major protein component of high-density lipoproteins (HDL), and albumin [275, 276].
The degree to which the carrier protein impacts the outcome of S1P-S1PR1 interactions
remains an open question. S1P-ApoM and S1P-albumin both stimulate the MAP kinase
cascade through S1PR1 to similar degrees in endothelial cells, but the intracellular tail of
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S1PR1 appears to bind differently to scaffolding proteins and promote different cellular
responses depending on the carrier [277, 278]. Surprisingly, S1P bound to ApoM
appears to be completely dispensable for T cell trafficking [253]. Even in mice doubly
deficient in ApoM and albumin, lymphopenia isn’t observed, although other proteins are
reported fulfill the S1P-carrying function in these animals [279]. It seems likely that
S1PR1-dependent T cell egress is largely indifferent to the S1P carrier protein so long
as sufficiently high S1P levels are maintained in the circulatory fluids. More work is
needed to verify that this is the case. Most of the in vitro data on T cell responses to
S1P, including the experiments detailed in chapters 2-3, utilize S1P conjugated to
albumin.

1.6

Structure of Thesis and Contributions
Following this introductory Chapter 1, this dissertation contains two chapters

(Chapters 2 & 3) devoted to data. Chapter 2 details our characterization of a novel
mouse model in which T cells are devoid of all ERM proteins, and concludes with the
major finding that ERM proteins are particularly critical for S1P-dependent egress in vivo
and S1P-induced migration in vitro. Chapter 3 then describes an atypical pressuredriven bleb-based mode of migration elicited by S1P, and how this contrasts with
standard actin-based motility elicited by chemokines. Chapter 3 concludes by showing
that ERM proteins are selectively critical for S1P-induced bleb-based migration because
they limit blebbing to the leading edge. In Chapter 4, I discuss the results from Chapters
2-3 with a particular focus on how S1P could elicit such a profoundly different mode of
migration than chemokines, and why bleb-based motility may be particularly useful for
crossing specialized endothelial barrier during egress events.
27

The contents of this dissertation contain modified text and figures from a
manuscript this is currently being revised for resubmission to the Journal of Cell Biology
with the following author list, title, author affiliations, and author contributions:

[Preparing Resubmission] Tanner F. Robertson1,2, Pragati Chengappa3, Daniela
Gomez Atria4, Christine F. Wu1,2, Lyndsay Avery1,2, Nathan H. Roy1,2, Ivan Maillard4,
Ryan J. Petrie3, Janis K. Burkhardt1,2. Lymphocyte Egress Signal Sphingosine-1Phosphate Promotes ERM-Guided, Bleb-Based Migration. Journal of Cell Biology (2021)

1

Department of Pathology and Laboratory Medicine, Children’s Hospital of Philadelphia
Research Institute, Philadelphia, PA, USA.

2

Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

3

Department of Biology, Drexel University, Philadelphia, PA, USA.

4

Division of Hematology-Oncology, Department of Medicine, Abramson Family Cancer
Research Institute, University of Pennsylvania Perelman School of Medicine,
Philadelphia, PA, USA.

Author Contributions
T.F.R. designed and executed most experiments, interpreted the data, and guided the
project. D.G.A and I.P.M designed and performed the immunohistochemistry studies,
and P.C. and R.J.P designed and performed the intracellular pressure experiments.
C.F.W assisted with T cell purification and culture, transwell migration assays, video
analysis, and western blots. L.A. helped design and execute competitive in vivo
28

migration experiments, and N.H.R provided conceptual and technical assistance with
cell motility and blebbing. J.K.B oversaw the project.

29

Splenic entry at marginal
zone, migration within
white pulp, egress
directly into blood

Egress from the thymus
directly into the vasculature
Lymph node entry
through high endothelial
venules

Lymphatics
merge with
vasculature at
the thoracic duct

Intranodal
migration and
search for antigen
Egress via the
efferent lymphatics

Entry into “downstream”
lymph node via afferent
lymphatics

Continued entry, intranodal migration, and
egress in subsequent lymph nodes

Figure 1.1. Diagram of T cell Homeostatic Immune Surveillance
T cell surveillance can be illustrated as a simple circuit. Moving clockwise, T cells first
egress from the thymus directly into the vasculature. From the blood, T cells enter into
lymph nodes through the high endothelial venules. Within the lymph node, T cells
search for cognate antigen, and, if unsuccessful, egress via the efferent lymphatics.
For lymph nodes that exist in series, these lymphatics carry the T cells directly into a
downstream lymph node, where the T cells continues to search for antigen and, if
unsuccessful, egress via the efferent lymphatics. The efferent lymphatics eventually
merge with the vascualture at the thoracic duct, which puts the T cell back into
circulation, permitting subsequent lymph node entry through the high endothelial
venules. T cells can also access the spleen through the blood. In this case, T cells enter
via the central arteriole, which places them at the marginal zone. These cells migrate
within the white pulp, and then egress directly into the vasculature.
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F-actin
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b.
Filipodia

c.
Blebs

Direction of Migration
Figure 1.2 Illustration of lamellipodia, filipodia, and blebs at the leading edge
Illustrations showing leading edge morphology in cells migrating with lamellipodia (a),
filipodia (b), or blebs (c). (a) In lamellipodia, actin organizes into a thin, flat meshwork.
(b) In filipodial migraton, actin organizes into long protrusive bundles. (c) In bleb-based
migration, the plasma membrane separates from the underlying actin cortex at the
leading edge.
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Figure 1.3. ERM Protein Structure, Function, and Conformational Regulation
(a) The domain organization ERM proteins. All ERM proteins have an N-terminal FERM
domain followed by an intermediary alpha-helical domain, a short linker region, and a
C-terminal region (C-ERMAD) that contains an actin-binding domain. The indicated
amino acid positions are for specific to ezrin, but radizin and moesin contain analogous
sites. The critical threonine residue, T5667, is shown. (b) In the open conformation (left)
ERM proteins simultaneously bind to PI(3,4)P2 in the inner leaflet of the plasma
membrane through their FERM domain and to the actin cortex through their C-ERMAD
region. In the inactive, closed conformation, the protein assumes a head-to-tail
autoinhibited conformation that masks the membrane- and actin-binding sites.
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CHAPTER 2: ERM DEFICIENCY RESULTS IN A T CELLINTRINSIC EGRESS DEFECT FROM LYMPHOID ORGANS

2.1

Results

ERM-deficient lymphocytes show an altered distribution among lymphoid organs
and blood
Co-expressed ERM proteins functionally overlap, and T cells express high levels
of both moesin and ezrin. We generated germline moesin knockout mice (MKO) by
targeted disruption of the Msn gene (Fig 2.1) and crossed them to mice with a
conditional deletion of Ezn in the T cell compartment (ezrinFlox/Flox:CD4Cre, EKO; [217]) to
generate animals in which mature T cells lack both gene products (double knockout,
DKO). These mice were born at expected Mendelian frequencies and were visibly
indistinguishable from wildtype littermates. Additionally, histological analysis did not
reveal any overt pathology or aberrant accumulation of leukocytes in non-lymphoid
organs (skin, liver, kidney, collected at 8-16 weeks of age, data not shown). Western blot
analysis of CD4+ T cells confirmed that ezrin and moesin were deleted as expected from
the single and double knockouts; radixin levels remained low (Fig. 2.2). Note that B cells
in both MKO and DKO mice lack moesin, but continue to express ezrin.
Analysis of secondary lymphoid organs from both MKO and DKO mice revealed
marked alterations in lymphocyte distribution. Spleens were larger in size compared to
WT mice and showed elevated cellularity and lymphocyte numbers, while inguinal and
mesenteric lymph nodes showed diminished total cellularity and T cell numbers (Fig.
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2.3a-e). Numbers of lymph node B cells were also reduced, although this did not reach
statistical

significance

(Fig.

2.3d-e).

Despite

these

alterations,

ERM-deficient

lymphocytes generally segregated into the correct anatomical locations within the
spleens and lymph nodes, although the organization of these zones was more diffuse
than in WT mice (Fig. 2.4a-g). Most striking, MKO and DKO mice displayed sharp
reductions in the numbers of all lymphocytes in the blood (Fig. 2.3f). Overall, the
phenotype of MKO and DKO mice was similar, but DKO mice consistently exhibited
more pronounced phenotypes. This likely reflects the fact that moesin is the more
abundant isoform in T cells, and the existence of functional overlap between ezrin and
moesin in this setting. Given the more profound defects in DKO mice, only these animals
were used for further experiments.
Within the thymus of DKO mice, double negative and double positive thymocytes
appeared in normal numbers and frequency, indicating no gross perturbations in T cell
development (Fig. 2.5a-b). CD4 and CD8 single positive populations showed a mild
increase; further analysis demonstrated that this was due to a significant accumulation of
mature (CD24low, S1PR1hi) single positive thymocytes (Fig. 2.5c-f). This phenotype as
well as the peripheral lymphopenia in DKO mice (Fig. 1f) are common features of mouse
models with egress defects from lymphoid organs [38, 39]. Taken together, these data
suggest that ERM proteins are important for homeostatic lymphocyte trafficking.
ERM deficiency results in cell-intrinsic defects in egress from lymphoid organs
To ask whether the altered distribution of ERM-deficient lymphocytes reflects a
cell-intrinsic trafficking defect, we performed competitive in vivo migration assays by
labelling congenic WT and DKO naïve CD4+ T cells with cell tracking dyes and co34

injecting them into the lateral tail veins of WT recipients (Fig. 2.6a). To distinguish
between entry and egress defects, cells were analyzed 1-hour after injection, when
egress is minimal, and 24-hours after injection, when trafficking is reaching equilibrium
[35, 280]. 1-hour post-injection, DKO T cells showed a 30-40% reduction in lymph node
entry and a corresponding elevation in the blood (Fig. 2.6b). This points to a role for
ERM proteins in promoting T cell passage into lymph nodes across high endothelial
venules. Entry into the spleen, which occurs via an open system continuous with blood
[281, 282], was equally efficient for WT and DKO T cells. By 24 hours, DKO T cells
accumulated in the spleen and showed a corresponding decrease in the blood (Fig.
2.6c), indicating that DKO T cells fail to egress properly from the spleen. The relative
paucity of DKO T cells in lymph nodes was maintained from 1 to 24 hours post injection,
most likely because the reduced entry rate evident at 1-hr is matched by a reduced
lymph node egress rate [35]. Importantly, the distribution of transferred T cells at 24
hours matched the altered tissue distribution observed in the DKO mice (Fig. 2.2),
indicating that the observed alterations in the DKO mice are T cell intrinsic. Taken
together, these studies show that although loss of ERM proteins impairs both entry and
egress from lymphoid organs, the egress defects drive the most profound phenotypes,
including accumulation of mature thymocytes, splenomegaly, and severe peripheral
lymphopenia. Thus, we focused on understanding the molecular basis for this egress
defect.
ERM proteins are selectively required for S1P-induced migratory responses
The central signal that governs lymphocyte egress from lymphoid organs is
sphingosine-1-phosphate (S1P), a pleiotropic signaling lipid that is rich in blood and
lymph but low in interstitial fluids of lymphoid organs [37]. T cells recognize S1P through
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the receptor S1PR1 (Edg1), which prompts egress [38, 39]. Our initial attempts to study
S1P-induced migration in WT and DKO T cells were stymied by the fact that T cells are
notoriously unresponsive to S1P in vitro [248, 249], a problem that is further complicated
by the presence of S1P in cell culture serum. In other cell types, optimal S1P responses
can be achieved by overnight culture in serum-free media [283], but this strategy results
in unacceptable levels of death for primary T cells (data not shown). To maintain T cell
viability, we utilized charcoal-stripped FBS (CS-FBS), which is devoid of lipophilic
components. T cells cultured overnight in media supplemented with CS-FBS were
mostly viable and displayed dramatically enhanced transmigration to S1P relative to
freshly-isolated cells cultured for one hour in the same media (Fig 2.7a). Inhibiting
S1PR1 with the selective antagonist Ex26 [284] completely abrogated transmigration,
verifying that the response was S1PR1-dependent (Fig 2.7a).
We initially hypothesized that T cells were sensing S1P during the isolation
process and subsequently endocytosing S1PR1, which diminished responsiveness in
our in vitro assays. However, freshly-isolated cells had only a slight reduction in surface
S1PR1 relative to those cultured overnight, which seemed insufficient to explain the
transmigration defect (Fig 2.7b). Although they started off with elevated F-actin content,
freshly isolated cells polymerized actin in response to S1P comparably to those cultured
overnight, with both groups returning to their own pre-stimulation set point (Fig. 2.7c).
Despite this grossly normal actin response, downstream signaling through the ERK1/2 or
AKT pathways in freshly isolated cells was severely reduced following S1P stimulation
relative to those cultured overnight (Fig. 2.7d). Notably, this defective signaling in
freshly-isolated cells did not extend to other chemoattractants like CCL19 (Fig. 2.7e).
Both the actin and signaling responses to S1P were blocked by Ex26, indicating S1PR1
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was driving both (data not shown). It remains unresolved why some aspects of S1PR1
function (actin responses) are intact in freshly isolated cells and others (signaling) are
defective. These data indicate that the actin responses can be at least partially
uncoupled from downstream signaling events and may indicate unique aspects of
S1PR1 regulation. Despite the unresolved aspects of the overnight culture procedure, it
provided a method for more rigorously testing T cell responses to S1P in vitro than
previously possible.
Using this improved in vitro approach, we found that DKO T cells were highly
defective in transmigrating towards S1P across multiple doses (Fig. 2.8a). Remarkably,
transmigration towards CCL19 or CXCL12, two chemokines involved in naïve T cell
trafficking [18, 285] was entirely normal (Fig. 2.8b-c). These data indicate that, while
ERM proteins are not required for directed T cell migration generally, they are selectively
critical for S1P-induced migratory responses. To understand why ERM proteins appear
selectively critical for mediating S1P responses, I examined the modes of motility elicited
by S1P versus chemokines in T cells. These experiments revealed fundamental
differences between the responses to these various chemoattractants that explain the
unique requirement for ERM proteins in S1P responses. These experiments are detailed
in the following section, Chapter 3.
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Figure 2.1 Schematic of Msn targeting strategy
The diagram shows the insertion of the trapping cassette into the first intron of
the Msn gene in 129/Sv ES clones (OST4322827), which were used to
generate the moesin knockout (MKO) mice used in this report.
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Figure 2.2 Verification of the deletion of ezrin and moesin
CD4+ T cells harvested from the spleens and lymph nodes of mice with a T cell
conditional deletion in ezrin (EKO), a germline deletion in moesin (MKO), or both (DKO)
were lysed and immunoblotted with a pan-ERM antibody and for GAPDH. The ezrin
(Ez) and moesin (msn) bands are noted.
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Figure 2.3. ERM-deficient lymphocytes assume an altered tissue distribution with
severe lymphopenia.
(a) Total cell counts from spleens (post-RBC lysis), inguinal and mesenteric
lymph nodes from 8-16-week-old mice. (b) Spleens from age matched mice of
the indicated genotype were weighed. (c-f) Cell suspensions and PBMCs were
labeled for the indicated surface markers, counted, and cell populations were
quantified using flow cytometry. Data in a-f represent means +/- StDev. Each dot
corresponds to an individual mouse. Statistical significance was determined
using a standard one-way ANOVA. *p<0.5, **p<0.01, ***p<0.001,****p<0.0001
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Figure 2.4 Organization of secondary lymphoid organs in DKO mice.
Immunofluorescence histology of spleens and lymph nodes from WT and DKO mice
stained with antibodies against CD3 (white), B220 (blue) and laminin (red). (a-b)
Confocal tile scans of whole spleens from WT and DKO mice, bar = 500 μm. (c-e)
Magnified regions of spleens with the central arterioles (arrows) and marginal zones
(MZ) labelled. Normal lymphocyte organization in WT and DKO spleens shown (c-d) as
well as a representative region of poor organization in DKO spleen (e), bar = 100 μm.
(f-g) Confocal tile scans of whole inguinal lymph nodes from WT and DKO mice, bar =
500 μm.
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Figure 2.5 ERM-deficiency results in the accumulation of mature, single
positive thymocytes
(a-b) Representative flow plots and total numbers of the major thymocyte populations based on CD4 and CD8 expression. (c-d) CD4 single positive populations further analyzed by CD24 and S1PR1 expression to determine the numbers of semi-mature (CD24Hi S1PR1Low) and mature (CD24Low S1PR1Hi) subpopulations in WT and DKO thymi. (e-f) CD8 single positive populations analyzed as
in (c-d). Statistical significance for b, d, f determined by comparing the WT and
DKO means using multiple t-tests and the Holm-Sidak method for correcting for
multiple comparisons. *p<0.05, **p<0.01
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Figure 2.6 ERM-deficient T cells have a cell-intrinsic egress defect
(a) Competitive in vivo migration experimental design. CD45 congenic WT and DKO
naïve CD4+ T cells labelled with CellTracker Green (CMFDA) were co-injected 1:1 into
the tail vein of WT recipient mice and harvested from the blood or indicated organ 1 hour
or 24 hours later. (b-c) The ratio of the number of transferred WT and DKO T cells isolated from blood, spleen, or lymph node at 1 hour (b) or 24 hours (c) post-transfer. Each
dot corresponds to a recipient mouse, pooled from two independent experiments.
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Figure 2.7 Overnight culture improves S1PR1 responses in T cells
Following isolation, naive CD4+ T cells were cultured either overnight (O.N) or for 1 hour
(1 Hr) in media supplemented with 10% charcoal-stripped FBS. (a) Percent transmigration of O.N. or 1 Hr cells towards the indicated concentration of S1P in the bottom chamber of a transwell chamber. Cells in the Ex26 group were pretreated with 100 nM of the
antagonist 20 minutes prior to the assay. Data pooled from 4 indpendent experiments.
(b) Surface S1PR1 levels of O.N. and 1 Hr cells were determined by flow cytometry.
Background (Bkgd) refers to cells stained without primary anti-S1PR1 antibody. Representative plot from 2 independent experiments. (c) O.N. and 1 Hr cells were stimulated
with S1P for the indicated amounts of time, fixed with PFA, stained with fluorescently-conjguated phalloidin, and analyzed by flow cytometry. Data is normalized to untreated O.N. cells and pooled data from 3 independent experiments. (d) O.N. and 1 Hr cells
were stimulated with S1P (1 nM), lysed after 0, 0.5, 2, or 5 minutes, and immunoblotted
for phospho-Erk (Thr2020/Tyr204), phospho-Akt (Ser473), and GAPDH. Only
performed once. (e) O.N. and 1 Hr cells were stimulated with S1P (1 nM) or CCL19 (100
ng/mL), lysed, and immunoblotted for phospho-Erk (Thr2020/Tyr204), phospho-Akt
(Ser473), and GAPDH. Only performed once.
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Figure 2.8 DKO T cells have a selective transmigration defect towards S1P.
(a-c) Percent transmigration of WT and DKO naïve CD4+ T cells cultured overnight to
the indicated concentration of S1P (a), CCL19 (b), or CXCL12 (c) in the bottom chamber
of a transwell chamber. Each data point represents one technical replicate from one
experiment, representative of 3-5 independent experiments. WT and DKO
transmigration means for each concentration of chemoattractant were compared with
t-tests. *p<0.05, **p<0.01.
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CHAPTER 3: S1P ACTIVATES MYOSIN TO PROMOTE BLEBBASED, ERM-GUIDED MOTILITY
3.1:

Results

ERM proteins are dispensable for S1PR1 expression and endocytosis
After identifying that ERM deficiency results in a T cell-intrinsic egress defect and
a corresponding defect in migration towards S1P, we next sought to determine how
ERM proteins facilitate S1P responses. Since cell surface expression of S1PR1 and
ligand-induced endocytosis are both known to impact S1P-dependent T cell egress [38,
39, 248, 249], we asked if ERM protein expression is required for these events. Across
multiple secondary lymphoid organs, surface S1PR1 levels on naïve DKO CD4+ T cell
were normal or slightly elevated (Fig. 3.1a). Surface S1PR1 expression also appeared
normal in mature DKO thymocyte populations (Fig. 2.5c, e). Additionally, DKO T cells
displayed low surface expression of S1PR1 when isolated from blood, a high S1P
environment, indicating that receptor endocytosis in vivo is intact (Fig. 3.1a). To confirm
that ERM proteins are dispensable for S1PR1 endocytosis, we treated cells with S1P in
vitro for 30 seconds or 10 minutes, stained for surface S1PR1, and measured loss of
receptor expression by flow cytometry. WT and DKO T cells showed similar surface
levels of S1PR1 in culture, and no differences were detected in the efficiency or kinetics
of endocytosis following S1P treatment (Fig. 3.1b-c). Thus, we conclude that receptor
expression and ligand-induced internalization are intact in the absence of ERM proteins.
ERM proteins are dispensable for S1P-dependent signaling
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Since ERM proteins interact with important signaling proteins at the PM [186], we
asked if DKO T cells show signaling defects downstream of S1PR1 ligation. Studies on
S1PR1 signaling in lymphocytes are lacking, but S1PR1 has been shown to signal
through the PI3K/Akt and MAP Kinase pathways in other cell types [268, 286]. We
stimulated WT and DKO T cells with S1P for various times and immunoblotted for
phospho-Akt and phospho-Erk1/2. Both the magnitude and kinetics of signaling were
similar for WT and DKO T cells (Fig. 3.1d). As a separate readout of S1PR1 signaling,
we measured actin polymerization, and found no differences in the response of WT and
DKO T cells (Fig. 3.1e-f). Treatment with the S1PR1 antagonist Ex26 effectively blocked
actin polymerization, confirming the receptor specificity of this response (data not
shown). Taken together, these studies show that ERM protein expression is not required
for ligand-induced S1PR1 internalization or signaling.
S1P treatment induces rapid dephosphorylation and rephosphorylation of ERM
proteins
Since S1PR1 appeared to be fully signaling-competent in DKO T cells, we
considered alternative explanations for the transmigration defects observed. ERM
proteins cycle between an activated conformation at the PM and an auto-inhibited headto-tail conformation in the cytoplasm [173]. Activation is mediated by binding of the Nterminal FERM domain to PIP2 in PM, and by phosphorylation of a critical threonine
residue in the C-terminal actin binding domain [181]. Chemokine receptor signaling in T
cells promotes potent ERM dephosphorylation lasting 10-20 minutes, during which time
the cell can undergo shape changes and molecular reorganization events needed for
polarized cell motility [184, 217]. We asked if ERM proteins cycle differently in response
to S1P stimulation. Interestingly, although both CCL19 and S1P induced ERM
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dephosphorylation at 30 seconds, dephosphorylation was sustained in the CCL19treated group, whereas S1P-treated cells showed rapid ERM re-phosphorylation
between 2- and 5-minutes post stimulation (Fig. 3.2a-b). Thus, the ERM-dependent
linkage of the actin cortex to the PM is largely intact during S1P but not chemokine
responses.
S1P induces a rapid, highly transient mode of motility that depends on ERM
proteins
To study the differences between S1P and chemokine induced migration, we
developed a chemokinesis assay to visualize cell responses following chemoattractant
stimulation. WT Naïve CD4+ T cells were added to chambers coated with vascular
adhesion protein-1 (VCAM), and imaged for several minutes at which point S1P, CCL19,
or CXCL12 was gently dripped into the chamber. Prior to stimulation, VCAM-bound cells
mostly exhibited a rounded morphology. Addition of S1P induced a rapid burst of
migration lasting only a few minutes, after which the cells rounded up and stopped
moving (Supplemental Video 1). In contrast, both CCL19 and CXCL12 induced modest,
but sustained, chemokinetic responses (Supplemental Videos 2, 3). Quantitative
analysis of cell velocity confirmed this distinction; S1P induced strong, but short-lived
responses that returned to baseline within 4-5 minutes whereas CCL19 and CXCL12
induced sustained migration (Fig. 3.3a). These distinct modes of motility are reflected in
the kinetics of F-actin polymerization, which is short-lived in S1P-stimulated cells and
sustained for at least 20 minutes in cells treated with CCL19 (Fig. 3.3b-c). Importantly,
during the time when S1P treated T cells exhibit maximal motility (approximately 2
minutes after stimulation, Fig 3.3a), ERM protein phosphorylation has already returned
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to significant levels (Fig. 3.2). This contrasts with chemokine-stimulated cells, where
phospho-ERM protein levels remain low during migratory responses (Fig 3.2).
We next used this chemokinesis assay to conduct side-by-side analysis of WT
and DKO T cells. We first quantified the number of cells that migrate in response to each
chemoattractant, using a threshold of at least 10 microns of displacement. Similar to the
transwell data (Fig 2.8a), fewer DKO T cells migrated in response to S1P (Fig 3.4a,
Supplemental Videos 1, 4), whereas the frequency of DKO cells migrating to CCL19 and
CXCL12 was normal (Fig. 3.4 b). Among the cells that did move at least 10 microns,
DKO T cells showed reduced displacement and directionality in response to S1P (Fig.
3.4c, e), but not in response to CCL19 or CXCL12 (Fig. 3.4d, f). These selective defects
in displacement and directionality are readily observed in plots of cell tracks (Fig. 3.4gh).
S1P induces pressurized, bleb-based migration
When quantifying WT and DKO T cell dynamics, we observed that although WT
cells responding to S1P and chemokines exhibited similar morphologies at early time
points, their behavior differed dramatically after the first 2-3 minutes. Prior to stimulation,
cells were rounded and poorly migratory (Fig. 3.5a-b, Pre-treat). Immediately after
stimulation with either S1P or chemokine (CXCL12 and CCL19 promoted similar
responses), T cells showed prominent membrane ruffling coincident with a burst of actin
polymerization (Fig. 3.5a-b, Ruffle, Fig. 3.3b-c). Both sets of cells then polarized and
began actively migrating. During this initial migratory phase (Fig. 3.5a-b, Lamellipodial),
both sets of cells exhibited broad, flat lamellipodia at the leading edge (arrowheads), and
a refractile uropod at the rear. For chemokine-stimulated cells, this morphology was
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maintained throughout the course of the assay. In contrast, S1P-stimulated cells
transitioned after 2-3 minutes from a lamellipodial mode of motility to one associated
with prominent membrane blebbing. Blebbing continued until the end of the migratory
response,

approximately

5

minutes

after

stimulation

(Fig

3.5a,

Bleb-based,

Supplemental Videos 5, 6). Blebs are sites of temporary PM separation from the actin
cortex [128, 152, 287]. By DIC microscopy, they appear as rapidly-forming balloon-like
protrusions (Fig. 3.5c). Blebs are highly transient in migrating cells, since actin-rich
structures fill the space within seconds. Enumeration of these structures revealed that
S1P stimulation drove a substantial increase in blebbing over unstimulated cells
(control), whereas chemokine stimulation did not (Fig. 3.5d).
Unlike lamellipodia, blebs are pressure-driven protrusions [287]. Intracellular
pressure is regulated primarily by actomyosin contractility [97]. To determine if S1P was
driving bleb-based migration through enhanced myosin activity, we treated cells with
either S1P or CCL19 and immunoblotted for phosphorylation of myosin light chain at
Thr18/Ser19. Phosphorylation at these sites enhances ATPase activity of the catalytic
head domain of myosin heavy chain and promotes contractility [115-117]. We also
probed for AKT phosphorylation as a positive control. S1P and CCL19 both drove
significant AKT phosphorylation at 0.5 minutes to similar degrees, but this response was
highly transient for S1P treated relative to CCL19 (Fig. 3.6a, b). As AKT phosphorylation
diminished, S1P-treated cells showed enhanced MLC phosphorylation peaking at 3.5
minutes post-stimulation (Fig. 3.6a, c), a time point that corresponds to high levels of
blebbing in the chemokinesis assay (Fig. 3.5a). CCL19 did not drive any elevation in
MLC phosphorylation, but did result in a substantial decrease at 0.5 minutes (Fig 3.6 a,
c).
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To determine if this myosin activation resulted in heightened intracellular
pressure that could be used to drive bleb formation, we utilized the servo-null
micropressure method, which uses a microelectrode to penetrate the cell membrane and
directly quantify cytoplasmic pressure, to determine intracellular pressure in T cells
[288]. Cells were left untreated (none) or stimulated with either S1P or CCL19, and
intracellular pressure was determined. As shown in Fig. 3.6d, S1P stimulation resulted in
a significant elevation in intracellular pressure, whereas CCL19 stimulation did not. To
determine whether this pressure increase was dependent myosin activity, we treated the
cells with the myosin inhibitor blebbistatin (BBS) prior to S1P stimulation. Treatment with
BBS alone in resting cells resulted in a significant drop in pressure, consistent with a
well-described homeostatic role for myosin contractility in regulating pressure [97]. Even
with their lowered starting values, BBS-treated T cells did not elevate their intracellular
pressure in response to S1P, indicating that myosin activity is necessary for S1Pinduced pressurization. To determine if myosin inhibition also prevented bleb-formation,
we repeated the chemokinesis assay in the presence or absence of BBS and quantified
bleb formation. As shown in Fig 3.6e, S1P induced prominent blebbing, but these
protrusions were potently inhibited by pre-treatment with BBS. Collectively, these data
indicate that S1P activates myosin to drive pressurized, bleb-based migration and that
this migratory response is fundamentally different from the responses elicited by CCL19
or CXCL12.
ERM proteins facilitate migration by limiting blebs to the leading edge
ERM proteins, which link the PM to the actin cortex, are known to play an
important role in bleb prevention and resolution [137]. We therefore compared bleb
formation in WT and DKO T cells during S1P-induced migration. At early times after S1P
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addition, WT and DKO cells ruffled, polarized, and began to migrate similarly (Fig. 3.7a).
However, when the transition to blebbing occurred, WT T cells primarily displayed
blebbing at or near the leading edge, whereas DKO T cells showed indiscriminate
blebbing all around the cell body (Fig. 3.7a, asterisks, Supplemental Videos 7, 8). To
quantify this, cells were divided into thirds along the axis of migration (rear, middle, and
front), and the front third was further divided into “front” and “lead” to distinguish blebs
that occur strictly at the leading edge. Examples of blebs occurring in each region are
shown in Figure 3.7b. Videos of WT and DKO T cells were then analyzed for the bleb
frequency within each region. Blebbing in the rear third of the cell was rarely observed in
either cell population. In WT T cells, blebbing was progressively more frequent in the
regions closer to the leading edge (Fig. 3.7c). Relative to WT cells, DKO T cells showed
elevated blebbing in the middle region and reduced blebbing at the leading edge (Fig.
3.7c). In WT T cells, bleb area also increased with proximity to the leading edge, with a
particularly sharp increase between the middle and front/lead regions (Fig. 3.7d). In
contrast, blebs in DKO T cells were large irrespective of location (Fig. 3.7d). This inability
to spatially regulate bleb frequency and size likely contributes to the profound
directionality defects displayed by DKO T cells responding to S1P (Fig. 3.4e).
Finally, we asked how the location of ERM proteins within the cell relates to
directional blebbing. WT T cells bound to VCAM were stimulated with S1P for 1, 2.5, or 5
minutes, after which they were fixed, labeled for phospho-ERM proteins and
counterstained for tubulin to identify the centrosome, which is positioned in the rear of
migratory lymphocytes. Consistent with the western blot data (Fig. 3.2), S1P drove an
initial dephosphorylation of ERM proteins that recovered after 2.5-5 minutes. At 2.5
minutes, when cells are highly migratory and beginning to bleb, phosphorylated ERM
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proteins primarily localized to the rear of the cell; labeling diminished gradually within the
middle region and was largely absent from the front third of the cell (Fig. 3.7e-f). By five
minutes post-stimulation, when cells have rounded up and ceased migration, active
ERM proteins were found all around the cell cortex. Importantly, the regions where ERM
proteins accumulate in WT cells correspond to regions of low bleb frequency. These are
the same regions that show elevated blebbing frequency and size in DKO T cells. Taken
together, these results show that ERM proteins in T cells are largely dispensable for
lamellipodial migration, but play a critical role in facilitating polarized protrusions during
bleb-based migration.
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Figure 3.1 ERM proteins are dispensable for S1PR1 expression, endocytosis, and
signaling.
(a) Ex vivo surface expression of S1PR1 on WT and DKO naïve CD4+ T cells (gated on Live,
CD4+, CD62LHi CD44Low) from the spleens, lymph nodes, and blood. Bkgd refers to WT
CD4+CD8+ thymocytes stained in parallel. Representative flow panels from 3 independent
experiments shown. (b-c) Ligand-induced S1PR1 endocytosis. WT and DKO naïve CD4+ T cells
were stimulated with S1P (10 nM) for 0, 0.5, or 10 minutes, stained for surface S1PR1, and
analyzed by flow cytometry. Bkgd refers to cells stained without primary anti-S1PR1 antibody.
Pooled data from 4 independent experiments normalized to WT levels prior to stimulation are
shown as means +/- StdDev and compared at each time point using an t-tests and the
Holm-Sidak correction for multiple comparisons. (d) S1P-induced signaling. WT and DKO naïve
CD4+ T cells were stimulated with S1P (1 nM), lysed after 0, 0.5, 2, and 5 minutes, and
immunoblotted for phospho-Erk (Thr2020/Tyr204), phospho-Akt (Ser473), total ERM proteins,
and GAPDH. Blot representative of 3 independent experiments. (e-f) S1P-induced actin
polymerization. WT and DKO naïve CD4+ T cells cultured were stimulated with S1P (1 nM) for 0,
0.5, 2, or 20 minutes, fixed, stained with phalloidin-AF488, and analyzed by flow cytometry.
Representative plots and pooled data from four independent experiments shown as means +/StDev and compared at each time point using multiple t-tests with the Holm-Sidak correction for
multiple comparisons. No statistically significant differences were observed between WT and
DKO T cell responses.
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Figure 3.2 S1P-induced ERM inactivation is short-lived relative to chemokine
(a-b) ERM dephosphorylation and rephosphorylation. WT naïve CD4+ T cells were
stimulated for 0, 0.5, 2, 5, or 15 minutes with S1P (100 nM) or CCL19 (100 ng/mL), lysed,
and immunoblotted for phospho-ERM (Thr558 for moesin) and total ERM. Quantified
band intensities displayed as the phospho/total ratio pooled from five independent
experiments. Means for the S1P and CCL19 group compared at each time point using a
multiple t-tests and the Holm-Sidak correction for multiple comparisons. *p<0.5

55

b.
Stim

S1P
CCL19

0.3

CXCL12

0.2
0.1
0.0

-2 -1 0

1

2

3

4

5

6

7

8

9 10

Minutes

5000

F-actin MFI

Velocity
(microns/second)

0.4

c.

4000

S1P
CCL19

3000

****

2000
1000
0

0 5 10 15 20

Minutes

100
80
60
40
20
0
80
60
40
20
0
80
60
40
20
0
100
80
60
40
20
0

Count

a.

0’

S1P
CCL19

0.5’

3

2’

3

10

10

20’

10

3

3

10

F-actin

10

10

10

4

4

4

4

10

Figure 3.3 S1P promotes a rapid, highly transient mode of migration
(a) Instantaneous velocity following S1P or chemokine stimulation. WT naïve CD4+ T
cells were imaged by DIC microscopy before and after stimulation with S1P (100 nM),
CCL19 (100 ng/mL), or CXCL12 (100 ng/mL), and manually tracked at one-second
intervals. Instantaneous velocities were smoothed over 5-second windows. Averages +
StDev for twelve representative cells per condition are shown. (b-c) Actin polymerization
kinetics following S1P vs Chemokine stimulation. WT naïve CD4+ T cells cultured
overnight were stimulated with S1P (1 nM) or CCL19 (100 ng/mL), fixed after 0, 0.5, 2,
or 20 minutes, stained for F-actin, and analyzed by flow cytometry. Representative data
from three independent experiments shown with representative flow plots (gated on
CD4+ singlets).
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Figure 3.4 ERM proteins are required for S1P-induced chemokinetic responses
Migration of WT and DKO naïve CD4+ T cells in response to S1P or chemokine. Cells
were added to VCAM-coated chambers and monitored by DIC microscopy following
stimulation with S1P (100 nM), CCL19 (100 ng/mL), or CXCL12 (100 ng/mL). (a-b)
Percentage of cells that displace at least 10 microns during the response. Each dot
corresponds to a field of cells pooled from three independent experiments shown. Mean
+/- Std Dev shown and compared individually using t-tests. (c-d) Displacement of WT
and DKO migratory cells following S1P or chemokine stimulation. Dashed lines show
10-micron threshold for analysis from (a-b). (e-f) Directionality of migratory WT and DKO
cells. Directionality was calculated by dividing displacement by total track length. For
(c-f), pooled data from three independent experiments displayed as individual cells (dots)
and means (horizontal bars) and compared using Mann-Whitney (non-parametric)
t-tests. *p<0.5, **p<0.01, ****p<0.0001 (g-h) Tracks of individual cells with the same
origin are shown, representative of three individual experiments.
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Figure 3.5 S1P promotes bleb-based migration
(a-b) Representative migratory responses for S1P vs chemokine. WT naïve
CD4+ T cells were imaged by DIC microscopy on VCAM-coated chambers
before and after stimulation with S1P (100 nM, (a)), CCL19 (100 ng/mL, not
shown), or CXCL12 (100 ng/mL, (b)). Scale bars = 5 micron. Time in min:sec
and relative to point of stimulation. Full arrows = direction of migration,
arrowheads = lamellipodia, asterisks = blebs. (c) Representative cell showing
the rapid formation and transient nature of blebs in migratory cells following S1P
treatment. Time in min:sec and relative to point of stimulation. (d) Bleb
quantitation following S1P or chemokine stimulation as in (a). Blebs were
manually counted from DIC movies of control, S1P-, or chemokine-stimulated
cells on VCAM. Each dot corresponds to a cell pooled from three independent
experiments. Means (horizontal bars) of S1P, CCL19, and CXCL12 groups
compared to control using a Kruskal-Wallis One-way ANOVA.
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Figure 3.6 S1P activates myosin to drive intracellular pressurization and bleb-based migration
(a-c) WT naïve CD4+ T cells were stimulated with S1P (1 nM) or CCL19 (100 ng/mL) for 0, 0.5, 2, 3.5, or 7
minutes and immunoblotted for phospho-AKT (pAKT; Ser473), total AKT, phospho-myosin light chain
(ppMLC; Thr18/Ser19), and GAPDH. A representative blot (a) is shown with quantitation pooled from four
independent experiments (b-c). S1P vs CCL19 AKT phosphorylation (b) was compared using a two-way
ANOVA with a Sidak correction for multiple comparisons. (c) Activation of myosin was determined using a
one-sample t test to determine if normalized ppMLC/GAPDH levels were significantly different from a
hypothetical mean of 1. (d) Intracellular pressure following S1P or chemokine stimulation. WT naïve CD4+ T
cells were added to PLL-coated plated and left untreated or stimulated with S1P (100 nM) or CCL19 (100
ng/mL), and pressure was measured by the servo null method between 0-12 minutes of sitmulation. Where
indicated, blebbistatin (50 micromolar) was added at least 30 mintues prior to stimulation and pressure
measurement. Each dot corresponds to a cell, pooled from 4 independent experiments. Means (horizontal
bars) of the S1P and CCL19-treated groups compared to control using a Kruskal-Wallis One-way ANOVA. (e)
Bleb quantitation following S1P or chemokine stimulation as in fig 3.5. Blebs were manually counted from DIC
movies of control or S1P-stimulated (100 nM) cells on VCAM. Where indicated, cells were pre-treated with
s-nitro-blebbistatin (5 micromolar) at least 10 minutes prior to stimulation and imaging. Each dot corresponds
to a cell pooled from one experiment. Means (horizontal bars) of S1P, CCL19, and CXCL12 groups compared
to control using a Kruskal-Wallis One-way ANOVA. **p<0.01,***p<0.001 ****p<0.0001
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Figure 3.7. ERM proteins facilitate S1P-induced migration by limiting blebs to the leading edge.
(a) Representative S1P-induced bleb-based migration for WT and DKO naïve CD4+ T cells. Cells were
imaged by DIC microscopy before and after stimulation with S1P (100 nM). Full arrows = direction of
migration, asterisks = blebs. Time in mm:ss relative to S1P stimulation. Scale bar = 5 microns. (b) An
illustration depicting a cell divided along the axis of migration and an example of S1P-induced blebs occurring
in each region (asterisks). Scale bar = 5 microns. (c-d) Bleb frequency and area along the axis of migration.
Individual cells were tracked during S1P-induced migration, and blebs were binned into the appropriate
region and area was measured. (c) More than 50 cells pooled from three independent experiments shown as
the mean +/- SEM compared using multiple t-tests and the Holm-Sidak correction for multiple comparisons.
(d) Each dot corresponds to an individual bleb (>300 per group), and means compared (red horizontal bars)
using a Kruskal-Wallis one-way ANOVA. **p<0.01, ****p<0.0001. Dashed line at WT lead mean. (e) Active
ERM protein localization during S1P migratory responses. WT naïve CD4+ T cells were stimulated with S1P,
fixed at the indicated time (minutes), stained for phospho-ERM proteins (top) and tubulin (bottom), and
imaged by confocal fluorescence microscopy. UT = untreated, scale bar = 10 microns. Cells outlined in yellow
in tubulin channel. Representative images from 3 independent experiments. (f) A representative cell from the
2.5-minute time point in (e) enlarged and oriented in the same direction as (b).
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CHAPTER 4: DISCUSSION
4.1 Summary and Reconciliation with Previous Work
The experiments detailed in this dissertation show that S1P promotes a mode of
cell motility in T cells that is fundamentally different from the response elicited by
chemokines. Rather than relying solely on actin polymerization-based lamellipodial
migration, S1P promotes pressurization and blebbing, a mode of migration typically
reserved for cells tasked with migrating in confinement. During this bleb-based migratory
response, ERM proteins localize to the rear and sides of polarized T cells where they
tether the membrane to the underlying actin cortex to limit bleb formation. This process
restricts blebbing to the leading edge, thereby promoting forward movement of the cell.
ERM-deficient T cells show dysregulated blebbing, resulting in compromised
chemokinetic and transmigration responses towards S1P in vitro and defective egress
from lymphoid tissues in vivo (modelled in Fig. 4.1).
The phenotypes of our MKO and DKO mice are essentially identical to those of
MKO mice independently derived by Hirata et al [224]. They also report lymphocyte
increases in the spleen, decreases in the lymph nodes, severe decreases in the blood,
and an accumulation of mature single positive thymocytes in the thymus [224]. While T
cells in these animals are ezrin-replete, our own data confirms that moesin deficiency
alone causes perturbations in T cell trafficking, despite the functionally overlapping roles
typically played by ERM proteins (Fig 2.3). In our hands, many of the trafficking
phenotypes observed in the MKO mice, including lymphocyte reductions in the blood
and lymph nodes are worsened by loss of ezrin (Fig 2.3). These data point towards
functional overlap between ezrin and moesin in T cell trafficking, but with moesin playing
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a more important role. This is likely due to the higher expression levels of moesin in T
cells (Fig 2.1). Hirata et al. further pinned down the cell-intrinsic egress defect by using
integrin-blocking antibodies to stop lymph node entry and show that moesin-deficient T
cells display significantly lowered egress rates from lymph nodes and the spleen alike.
With the cell-intrinsic egress defect well-established by our work and that of Hirata et al.,
I focused most of my efforts on understanding the cellular and molecular biology behind
this egress defect.
Hirata et al. report that MKO T cells show defective actin polymerization in
response to S1P, and a follow-up report by the Hirata group (Nomachi et al. [289]) finds
that moesin is required for S1PR1 endocytosis. Curiously, Nomachi et al., in direct
contraction to the previous paper, shows that MKO T cells display enhanced
transmigration towards S1P. This enhancement is observed without any drug treatment,
but is made more prominent when WT and MKO T cells are isolated from mice treated
with FTY720, an S1PR1 functional antagonist that works by driving sustained S1PR1
internalization and subsequent unresponsiveness to S1P [289]. No attempts were made
to resolve this contradiction; indeed, the first paper is cited only in regard to the
generation of the moesin knockout mouse. Like the initial Hirata paper, we show that
ERM-deficient T cells display diminished S1P transmigration (Fig 2.8). In our hands,
ERM deficiency had no effect on resting surface S1PR1 levels, consistent with the initial
Hirata paper (Fig 3.1). Moreover, our quantitative analysis showed no change in the
magnitude or kinetics of ligand-driven receptor endocytosis or actin polymerization (Fig
3.1). The basis for these discrepancies is unclear, but one major difference is our use of
an optimized overnight cell culture protocol, which results in robust responses more
suitable for quantitative analysis (Fig. 2.7).
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Poor in vitro responses to S1P have long plagued the T cell field, and our
overnight culture approach allowed us to address fundamental questions about S1Pinduced T cell migration. In the sections that follow, I address two major questions that
emerge from my work. First, how does S1PR1 instruct such a profoundly different
migratory response than the chemokine receptors tested in this report (4.2)? Second,
among the various protrusions a T cell can make, are blebs particularly well-suited for
passage through specialized endothelial layers during egress (4.3)?
4.2 S1PR1 vs Chemokine Receptor Signaling
One of the major findings from my work is that chemokines prompt lamellipodial
migration in T cells, whereas S1P prompts initial lamellipodial migration followed by
subsequent myosin-dependent bleb-based migration. S1PR1, CCR7, and CXCR4, the
receptors tested in my experiments, are all GPCRs, but S1PR1 belongs to the Edg
family of GPCRs along with other S1P and LPA receptors, whereas CCR7 and CXCR4
are both members of the chemokine receptor family. Chemokines, by definition, are
proteins [290], whereas both S1P and LPA are lipids. While S1PR1 is commonly lumped
in with the chemokine receptors during discussions of T cell trafficking, it is worth noting
that phylogenetic analysis of Edg and chemokine receptor families reveals these two
groups are evolutionarily distinct from one another [291, 292]. Despite these genetic
differences, side-by-side comparisons of cellular responses following Edg vs chemokine
receptor ligation are rare. All of these GPCRs transmit signals by coupling to
heterotrimeric G proteins, which are typically classified by their alpha subunits. These
alpha subunits are organized into four distinct families: Gαs, Gαi, Gαq, and Gα12 [293].
S1PR1, CCR7, and CXCR4 all associate with and signal through Gαi under normal
circumstances [294-299]. As expected, knockout of Gαi or inhibition with pertussis toxin
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potently interferes with numerous aspects leukocyte trafficking and chemotaxis,
including S1PR1- and CCR7-dependent processes for T cells in vivo [300-304].
While Gαi appears to be crucial for the signaling of all three receptors, it remains
unclear how the same G alpha protein could mediate the diverse effects observed
following S1PR1 vs CCR7/CXCR4 ligation. In addition to signaling through G alpha
proteins, GPCRs can also signal through GRK family proteins, which phosphorylate the
intracellular

tail

of

activated

receptors

[305].

Classically,

the

GRK-mediated

phosphorylation of active GPCRs and their subsequent arrestin-mediated endocytosis is
associated with signal termination [306-308]. However, more recent data indicate that
GRK proteins can influence and sustain GPCR-dependent signaling by serving as a
protein scaffold [309]. This phenomenon is almost exclusively studied outside the
context of either leukocytes or cell migration, so there is limited evidence to suggest that
differential GRK usage between S1PR1 and CCR7/CXCR4 receptors mediates the
different responses elicited by each receptor detailed in this report. That being said, the
existing data points towards some interesting differences. First, unlike for Gαi, CCR7 and
CXCR4 utilize a different GRK protein than S1PR1. CCR7 and CXCR4 are both
phosphorylated by GRK6 under most circumstances [310-312], whereas S1PR1 utilizes
GRK2 [248]. GRK6 and GRK2 are in different subfamilies and localize to active GPCRs
at the PM by completely different mechanisms: GRK6 is palymitoylated and therefore
membrane-bound, whereas GRK2 is cytoplasmic and binds to βγ subunits that have
dissociated from Gαi following activation [309, 313-315]. Deletion of GRK6 enhances or
prolongs chemokine receptor signaling for CCR7 and CXCR4 [311, 312]. A similar
enhancement has been reported for S1PR1 in T cells deficient in GRK2 for in vitro
migratory responses, but it is worth noting that GRK2-deficiency results in lymphopenia,
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which is more suggestive of defective S1PR1 function in vivo [248]. The existing data
points towards some potentially important differences in GRK protein function
downstream or S1PR1 vs CCR7/CXCR4, but dedicated studies are required to
determine what impact, if any, these have on the mode of motility elicited by ligation of
these different receptors.
An important component of dissecting differential GPCR function will be to look
directly at Rho GTPase activation. GPCRs that modulate cell migration typically exert
their effects through the activation of the Rho superfamily of small GTPases, which
include the Rac, Rho, and Cdc42 subfamilies. Classically, Rac activity is necessary for
lamellipodia formation, Cdc42 for filopodia formation, and Rho for contractility [316-319].
For T cells, chemokine receptor signaling typically activates Rac, while S1PR1 signaling
activates Rho but not Rac [320]. These authors measured Rac activation at 2-minutes
post-stimulation, so it is presently unclear if S1P does not activate Rac or if the authors
simply measured too late [320]. Time course studies looking at Rac vs Rho activation
following S1P and chemokine stimulation are warranted. While we did not specifically
measure Rac or Rho activation, the literature is consistent with our data showing that
CCL19 and CXCL12 promote lamellipodia formation and S1P promotes myosindependent blebbing (Fig 3.5). Interestingly, LPA signaling through the receptor Lpar2
also promotes robust Rho activation in T cells [321], indicating that Rho activation may
be a common feature of Edg family receptors in T cells.
Notably, S1PR1-dependent activation of Rho is not observed in most cell
systems. In Chinese hamster ovary epithelial cell lines (CHO) [322], primary human
umbilical vein endothelial cells (HUVECs) [323-325] and megakaryocytes [266], S1PR1
activates Rac, often without any detectable Rho activation. Yet in some cell lines,
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S1PR1 drives modifications of cell-cell adhesions through Rho and not Rac [326]. This
differential activation of Rac and Rho through S1PR1 in various cell types may help to
explain why S1PR1 ligation results such disparate biological outcomes for different cell
types, as detailed in the Introduction. One group has attributed these Rac/Rho
discrepancies to different S1PR1 expression levels among different cell types or
experimental conditions [327], but I propose here an alternative explanation: endocytosis
of the receptor.
Classically, GPCR endocytosis is associated with signal extinction, but recent
reports have shown that some GPCRs not only continue to signal following ligandinduced internalization but engage different signaling cascades from intracellular
organelles than they do from the plasma membrane [269]. S1PR1 has been shown to
signal for hours from endosomes in CHO cells when stimulated with the agonist FTY720
[268]. However, prolonged endosomal signaling in this study is likely secondary to the
fact that FTY720 cannot be degraded easily by cells through normal S1P lyasedependent mechanisms [328]. Still, the natural ligand S1P has been shown to both ligate
and activate S1PR1 in endosomes in HeLa cells in the context of endosomal maturation
[273]. Whether endosomal S1PR1 signals in T cells is unknown. Notably, T cells appear
much more sensitive to ligand-induced S1PR1 endocytosis than endothelial cells [267].
Therefore, S1PR1 signaling differences at the PM vs endosomes could begin to explain
and reconcile the aforementioned Rho GTPase data in T cells vs other cell types as well
as the different biological outcomes mediated by S1PR1.
In further support of this hypothesis are our data showing that S1PR1 doesn’t
immediately promote blebbing, but instead drives a delayed lamellipodia-to-bleb
transition. If S1PR1 switched from signaling through Rac at the PM to signaling through
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Rho in endosomes, it would explain why S1P-stimulated T cells first utilize lamellipodia
and only transition to myosin-dependent blebbing after 2-3 minutes, when the receptor is
mostly internalized (Fig 3.1, 3.5, 3.6). This mechanism could also explain why GRK2deficient T cells are hyper-responsive to S1P in transwell assays, but potentially
defective at actual in vivo egress [248]. Sustained Rac activation at the plasma
membrane may be sufficient for migration through transwell pores, as this would mimic a
CCR7 response, but if subsequent activation of Rho by internalized S1PR1 was critical
for actual passage through lymphatic endothelial cells in vivo, it would create an in vitro
vs in vivo discrepancy like the one observed [248]. Although I was unable to address this
particular hypothesis during my thesis work, other members of the Burkhardt lab are
currently doing so by using inhibitors of clathrin-mediated endocytosis to elucidate the
role of S1PR1 subcellular localization on signaling and T cell migratory responses.
In summary, the signaling and cellular responses elicited by S1PR1 in T cells is
simultaneously distinct from chemokine receptors in T cells and from S1PR1 in
endothelial cells. Despite using the same G alpha protein, S1PR1 and CCR7/CXCR4
elicit fundamentally different migratory response in T cells, with S1P uniquely activating
bleb-based motility. S1PR1 utilizes a different GRK protein and activates different small
GTPases than the aforementioned chemokine receptors, which likely mediate the
different migratory responses observed in these experiments. The S1PR1-dependent
activation of Rho reported by Mou et al. [320] appears to be atypical and may be limited
to lymphocytes due to significant differences in ligand-induced receptor internalization
and shuttling between lymphocytes and endothelial cells. While data on the signaling
cascades needs to be clarified, our data provides a mechanistic explanation for how
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S1PR1 uniquely promotes blebbing: through myosin activation and intracellular
pressurization.
4.3 The role of lamellipodia, blebs, and other protrusions for migration in vivo
Perhaps the most obvious question arising from my finding that S1P promotes
bleb-based migration is why would an egress signal specifically promote blebbing? Are
blebs better-suited for breaching the lymphatic sinuses or splenic vasculature where
egress occurs than actin-based protrusions? Understanding the role of the specific
types of protrusions during T cell trafficking is difficult for several reasons. First, live
intravital imaging experiments, while incredibly informative, often lack the spatial or
temporal resolution to definitively identify different protrusive structures. The model
organism best-suited for live cell imaging, the zebrafish, lacks lymph nodes, which
precludes studies of intranodal migration or typical egress events. Relative to other
protrusions, blebs are particularly transient and protein-dim, making them hard to
visualize during intravital imaging experiments in mice. However, careful interpretation of
in vitro migration studies and in vivo phenotypes can begin to clarify how various
protrusions facilitate different aspects of T cell trafficking. This section begins with a
summary of how different protrusive structures – especially lamellipodia and blebs –
facilitate migration in different contexts in vitro and in vivo and ends with a focus on the
morphology of egress portals as it relates to bleb-based passage.
One particularly crucial distinction between lamellipodial and bleb-based
migration is that lamellipodial migration requires an adhesive substrate, typically
provided in the form of immobilized integrin ligands, whereas bleb-based migration
occurs optimally in minimally adhesive settings, not requiring any specific adhesive
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contacts [128]. Intravital imaging experiments have shown that T cells migrate directly on
the network of FRCs in the paracortex [27], which indicates some kind of contactdependent guidance, presumably through one or more adhesive interaction. While FRCs
express the ligands for LFA-1 (ICAM-1) and VLA-4 (VCAM-1), integrins seem to play
only a minor role in intranodal T cell migration [329]. Woolf et al. found that LFA-1deficient T cells show only modest speed and directionality defects relative to WT T
cells, and that VLA-4 does not provide any compensatory adhesive interactions [329].
Similarly, deletion of all integrins from dendritic cells doesn’t detectably impact migration
to and within lymph nodes [330]. Therefore, while LFA-1 plays a critical role in lymph
node entry through HEVs, it is not particularly important for intranodal migration.
Another candidate for an adhesive ligand that could facilitate lamellipodial
migration is CCL21. Unlike CCL19, CCL21 remains immobilized on the surface of FRCs
[331-334]. Surfaces coated with CCL21 alone, in the absence of any integrin ligands,
promote profound and sustained migration of mouse or human T cells, suggesting that
CCR7 can function as a weak adhesive receptor in its own right [329]. In this study,
Immobilized CCL21 drives lamellipodial formation in T cells in the absences of any other
receptor engagement. Moreover, CCL21 is a potent activator of Rac in T cells and Rac
is crucial for intranodal migration [320, 329, 335]. Likewise, CCR7 deficiency has a much
more profound impact on intranodal T cell migration than LFA-1-deficiency does, even
when HEV entry is bypassed [31]. Although further study is warranted, these data point
towards a model where immobilized CCL21 promotes Rac activation to drive
lamellipodial T cell migration on the FRC network in the paracortex. Utilizing
lamellipodial migration in the paracortex likely has an added benefit, as T cell receptors
within lamellipodia are particularly sensitive to stimulation [336, 337]. Thus, a single
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protrusive structure could facilitate both migration and the scanning of APCs that have
collected in the paracortex for rare, cognate antigen [338].
While intravital imaging studies have shown that T cells are almost always
associated with the stromal network in the paracortex, T cells do occasionally appear
either weakly associated or fully detached from any FRC [27]. In vitro studies have
shown that T cells can migrate in collagen matrices in the absence of any specific
integrin ligands or immobilized chemokines, a process that is especially important in
non-lymphoid organs where specialized FRC networks are not present [339, 340]. Work
by Lämmerman et al. found that dendritic cell migration through collagen gels was
independent of integrins or any specific adhesive interactions, instead relying heavily on
Cdc42 activity and actomyosin contractions [330, 341]. Notably, Cdc42 is much more
critical for three-dimensional collagen matrix migration than two-dimensional adhesiondependent migration [341]. The authors were unable to study Cdc42-deficiency during
intranodal migration because the defect in these cells in getting to the lymph node was
too profound [341]. In three-dimensional environments, the leading edges of leukocytes
are often broad and actin-rich, but lacking the telltale characteristics of both lamellipodia
or filipodia and therefore are more aptly referred to simply as pseudopods or leading
edges. The role of Cdc42 in T cell migration has been difficult to study due to the fact
that this GTPase is absolutely critical for T cell development [342, 343], but these data
collectively point towards Cdc42 being especially important in leukocytes for adhesionindependent, actin-based migration in three-dimensional environments.
Rho-depleted T cells either fail to polarize or they show defects in trailing edge
retraction that results in inefficient transendothelial migration in vitro [344]. To my
knowledge, intravital imaging studies have not been performed for Rho-deficient T cells,
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but T cells deficient in myosin, the major Rho effector protein, display defective motility
within the lymph nodes [345]. However, these defects in intranodal migration are mild
compared to Rac-deficiency: Rac-deficient T display a roughly 70% decrease in median
instantaneous velocity compared to a 30% decrease for myosin-deficient T cells [335,
345]. In addition to their mild intranodal migration defects, myosin-deficient T cells
display decreased entry into lymph nodes, often remaining bound to HEVs apparently
unable to transverse. These cells are also retained in lymph nodes for abnormally long
periods of time, suggestive of an egress defect, although egress has not been directly
tested [345]. Mou et al [320] showed previously that S1P selectively activates Rho in T
cells, and we now demonstrate S1P activates myosin to promote bleb-base migration
(Fig 3.6). Consistent with a barrier-crossing role for myosin, in vitro studies have shown
that myosin becomes increasingly important for T cell transwell migration as the pores
become increasingly narrow and restrictive [346]. Taken together, these data support a
model in which S1P signaling through S1PR1 activates Rho to promote myosindependent bleb-based migration, which in turn promotes passage through confined
spaces, and egress from lymphoid organs.
To summarize, the functions of Rac, Cdc42, Rho, and their associated
protrusions in leukocyte migration are diverse, and their depletion or inhibition often
results in complex phenotypes. However, the extant data on leukocytes point towards
Rac being particularly critical for adhesion-mediated migration on FRC networks, Cdc42
being particularly critical for adhesion-independent migration in extracellular matrices,
and Rho being particularly critical for myosin-dependent rear retraction and barrier
crossing events. In this context, we propose that S1P induces lymphatic sinus and
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splenic endothelial crossing events by promoting myosin-dependent blebbing rather than
relying solely on actin-based protrusions.
Egress portals are unique barriers
This leads to most important topic in this discussion, which is the question of why
blebs useful for egress. To begin to answer this question, I will first discuss in vitro data
and modeling that compares the effectiveness of actin-based and bleb-based motility in
varying contexts. This will then be followed by a discussion of the morphology of the
endothelial barriers that stand between T cells and the circulatory fluids, where blebs are
implicated for passage.
One particularly salient study (Tozluoğlu et al. [347]) modeled the migration of
metastatic cancer cells, which show extreme plasticity in their protrusion type, in three
separate environments: two-dimensional surfaces, continuous confinement, and
discontinuous confinement. Continuous confinement is similar to migration in a
microchannel, and discontinuous confinement is more akin to a dense collagen gel with
various pore sizes that must be traversed. In line with previous experimental data, these
models predict blebs to be minimally effective in two-dimensions, where actin-based
protrusions are preferred [347, 348]. Both actin-based and bleb-based migration are
effective in continuous confinement, but somewhat surprisingly, blebs are significantly
more effective than actin-based protrusions in discontinuous confinement, especially
when adhesive ligands are scant or entirely absent [347]. These models predict that the
pressure-driven nature of blebs allows them to easily find pre-existing discontinuities in
the complex matrix, allowing the cell to identify paths of least resistance.

72

How do paths of least resistance relate to cells traversing an endothelial layer
during egress? Most endothelial layers form tight, continuous “zipper-like” cell-to-cell
junctions that do not resemble the discontinuous confinement modeled by Tozluoğlu et
al. [347], and T cells conspicuously do not use S1PR1 or blebs to cross at these sites,
instead relying on chemokine receptors and actin-rich podosomes [349, 350]. However,
Baluk et al. [351] report that blunt-end lymphatic sinus endothelial cells, where S1PR1dependent egress occurs, form overlapping flaps with discontinuous adhesion
molecules, resulting in “button-like” barriers [351]. These button-like barriers permit
perpetual passage of fluid into lymphatics, which is important for antigen delivery to
lymph nodes and the prevention of edema. Leukocytes enter these sinuses by
squeezing through pre-existing discontinuities in the sinus barrier [352]. These “buttonlike” vessels were initially described from imaging studies of lymphatics that drain
peripheral non-lymphoid tissues, and were observed at entry sites but not deeper into
the vessels, where lymph needs to be efficiently transported [351]. The morphology of
lymphatic sinuses in lymph nodes is less well-characterized, due in part to the extreme
heterogeneity of lymphatic endothelial cells in these sites [353]. Our understanding of
the morphology of sinuses in the lymph node cortex comes almost entirely from electron
microscopy characterization of lymph nodes from various species conducted from the
1960s to 1980s. While some reports concluded that LEC layers in lymph nodes are
continuous [354], others report the presence of pre-existing discontinues on the scale
reported by Baluk et al. [351] for peripheral lymphatics, some of which are filled with
transmigrating leukocytes [353, 355-358]. T cell tracking in lymph nodes has shown that
T cells tend to enter lymphatic sinuses through common portal sites, which is consistent
with the presence of preformed discontinuities [36, 359].
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More research dedicated to the morphology of LEC barriers in lymph nodes is
warranted, but the existing data point towards discontinuous barriers being common at
the regions where S1PR1-dependent egress occurs and where blebs are implicated. For
T cells interacting with these lymphatic sinuses and sensing S1P, blebs may
preferentially expand into these spaces between the “buttons” to pass from the lymph
node parenchyma into the sinus. While the spatial and temporal resolution from the
available intravital imaging studies is not high enough to confidently determine protrusive
structures, T cells transmigrating in vivo appear to squeeze through adjacent LECs with
large, rounded leading edges, potentially indicative of a bleb-based mechanism [36,
359]. This consistent with electron micrographs showing invasive adenocarcinoma cells
accessing peripheral lymphatics by extending rounded cytoplasmic projections, likely
blebs, between adjacent LECs [360].
Almost everything that is known about tissue architecture at egress sites comes
from analysis of lymph nodes, however S1P is also important for egress from the thymus
and spleen, which occurs either primarily or exclusively into blood rather than lymph [39,
235, 361]. It is unclear if these vascular entry points resemble typical zipper-like blood
endothelium or button-like lymphatic sinuses. Egress from the spleen has never been
visualized despite extensive efforts, and the egress sites are unknown [46]. Vascular
egress sites in the thymus, however, have been relatively well-characterized. Egress
from the thymus occurs through blood vessels at the corticomedullary junction [361,
362]. These vessels are surrounded by a prominent perivascular space (PVS), which is
further separated from the thymic epithelial space (TES) where thymopoiesis occurs by
a prominent basement membrane and epithelial sheath [361, 363, 364]. PVSs are
common in the brain, but uncommon in peripheral tissues where podosome-dependent
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processes are thought to mediate T cell barrier crossing [365]. This PVS is often
occupied with mature single positive thymocytes in the process of egressing, and forcing
premature expression of S1PR1 causes a prominent accumulation of immature
thymocytes in the perivascular space followed by their eventual release into circulation
[361, 366]. It is unclear if S1PR1 only facilitates movement from the TES into the PVS or
if it is also necessary subsequent passage into the venule. Notably, early electron
microscopy studies of the rodent thymus demonstrated that thymocytes appear to
breach this epithelial sheath surrounding the PVS through pre-existing discontinuities in
the barrier [367, 368], suggesting this S1PR1-dependent step may occur in a similar
fashion as lymphatic egress.
The emerging picture from these data is that the specialized entry and egress
sites that facilitate homeostatic T cell trafficking are structurally different from “textbook”
peripheral blood endothelial layers, and that these atypical structures may be particularly
permissive to bleb-based passage. While chemokines are critical for passage across
blood endothelial layers in vitro and in vivo [369], S1P is selectively critical for passage
across lymphatic endothelium in vitro and in vivo [256]. This relationship between
endothelial morphology and the permissiveness to different protrusions warrants further
study, especially considering the central role that transendothelial migration plays in
inflammatory diseases and the metastatic spread of cancers.
Concluding Remarks
Sphingosine is named after the Sphinx, a human/bird/lion hybrid in Greek
mythology that devours travelers if they cannot answer her riddle: What goes on four
feet in the morning, two feet at noon, and three feet in the evening? It was named after
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the sphinx as a nod to the enigmatic, frustrating nature of the lipid [233, 370]. The fact
that this riddle pertains to movement is purely coincidental. I can personally attest that
S1P does justice to the family name, but I believe the data outlined in this thesis have
begun to clarify the unique role for this lipid in T cell trafficking.
The role of blebs in T cell trafficking will be most directly solved by in vivo
imaging, but current technology is unlikely to be able to detect blebs in lymph nodes.
There are some compromises that can be made, however. If S1PR1-mediated egress
from peripheral tissues also promotes bleb-based motility, substantially higher temporal
and spatial resolution can be observed in ear explant imaging experiments, as routinely
performed by Michael Sixt’s lab (Compare, for instance, supplementary movie 3 in
Grigorova et al. 2008 [36] to videos 4-6 in Pflicke et al. 2009 [352]). Zebrafish have
lymphatic networks extremely similar to those present in mammals [371, 372], and may
therefore be useful for determining the role of blebs in leukocyte trafficking. Zebrafish are
the primary model organism where bleb-based motility has been unambiguously
observed in vivo, although these observations are limited to primordial germ cell
migration [135, 150, 373, 374].
Migration throughout the host is an incredibly complex process, and there are
undoubtedly still many Sphinxes with many riddles. I hope the contributions detailed in
this report add to our collective understanding of leukocyte trafficking and provide a
foundation for future studies on S1P, blebbing, and egress.
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Figure 4.1 A model for the role of ERM proteins in lamellipodial and
bleb-based migration
Illustrations showing cell morphology and protrusive structures in WT and
ERM-deficient T cells migrating using lamellipodia (left) and blebs (right).
Lamellipodial migration appears largely unaffected by the absence of ERM
proteins. Wild type cells migrating by blebs primarily show protrusions at the
front or leading edge of the cell. When a bleb forms outside the front region of
the cell, it is typically small. This polarized blebbing is facilitated by the rearward
localization of ERM proteins. In the absence of ERM proteins, blebs form
indiscriminately over the cell body, precluding efficeint directional migration.
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Materials and Methods
Mice. Moesin knockout mice were generated by and purchased from the Texas A&M
Institute for Genomic Medicine. A gene trap vector was inserted into the first intron of the
Msn gene on the X chromosome in 129/Sv ES clones (OST432827), and live mice with
germline insertion were generated on the 129Sv x C57BL/6 background. The resulting
moesin knockout (MKO) mice were backcrossed for ten generations to mice of the
C57BL/6 background (Jackson Laboratories). Mice homozygous for a floxed ezrin gene
and transgenic for CD4-Cre (EKO, previously described in Shaffer et al. 2009 [217]) on
the C57BL/6 background were then crossed to the MKO mice, to generate mice bearing
germline deletion of moesin and deletion of ezrin late in T cell development (female:
Msn-/-Ezrinflox/floxCD4-Cre+ or male: Msn-/YEzrinflox/floxCD4-Cre+). Loss of moesin and ezrin
expression in mature T cells was confirmed by RT-PCR and western blotting. For most
experiments, sex-matched WT littermates were used as controls. Age and sex matched
controls were used when littermates were not available or possible. All mice were
housed under barrier conditions in the Children’s Hospital of Philadelphia animal facility,
in accordance with protocols approved by the Institutional Animal Care and Use
Committee.
Flow Cytometry. Spleens, lymph nodes, and thymi were harvested from 8-16-week-old
mice, and single cell suspensions were prepared. PBMCs were isolated with
Lymphoprep (STEMCELL). Cells were counted and stained with fluorochromeconjugated antibodies towards CD3, CD4, CD8, CD44, CD62L, B220, and NK1.1
(Biolegend, BD Biosciences, Tonbo) and live-dead aqua or blue (Thermo Fisher
Scientific). For S1PR1, staining was done in lipid-free FACS buffer (PBS + 1% CS-FBS
+ 1 mM EDTA). Cells were stained sequentially with rat anti-S1PR1 (R&D MAB7089),
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donkey anti rat IgG-biotin F(ab’)2 (Jackson Immunoresearch 712-066-153), and
Streptavidin-APC (Biolegend 405207). For S1PR1 endocytosis experiments, cells were
stimulated with S1P (10 nM) for the indicated times, and endocytosis was stopped by
adding ice-cold PBS and washing twice with lipid-free FACS buffer prior to surface
staining. For F-actin measurements, cells were stimulated with S1P (1 nM) or CCL19
(100 ng/mL) and fixed with 3% paraformaldehyde at the indicated times. Cells were then
permeabilized with PSG (PBS + 0.01% saponin + 0.25% fish skin gelatin) and labeled
with phalloidin Alexa Fluor 488 (Invitrogen) and anti-CD4-APC (RM4-5, BioLegend). All
samples were analyzed on either an LSR Fortessa or LSRII (BD biosciences) equipped
with FACSDiva software (BD Biosciences). Data was analyzed using FlowJo software
(v.10.4.2).
Immunofluorescence on tissue sections. Spleens and lymph nodes were fixed for 2-4
hours in 4% PFA in PBS, washed, and incubated overnight in 30% sucrose in PBS.
Tissues were embedded in OCT and sectioned using a crytostat. Sections were blocked
for 30 minutes in staining solution (5% donkey serum in PBS-Tween) containing
FcRblock and subsequently incubated overnight at 4°C in staining solution with 1-2
ng/µL of fluorescently-labelled anti-mouse antibodies against CD3-AF647 (Clone 17A2,
Biolegend), B220-BV421 (Clone RA3-6B2, Biolegend) and Laminin 1+2 (rabbit antimouse, AB7463, Abcam, labelled with CF568 Mix-n-stainTM antibody labelling kit from
Biotium). After washing in PBS, slides were mounted using ProLongTM Diamond antifade
(Invitrogen), and imaged at 10-20X using a Zeiss LSM710 confocal microscope. Images
were processes and analyzed using Zeiss Blue 3.1 (Zeiss) and Volocity 6.3. (Perkin
Elmer) software.
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Competitive In Vivo Migration. Naïve CD4+ T cells isolated from the spleens and
lymph nodes of age and sex matched DKO (CD45.2+) and congenic WT CD45.1+
B6.SJL-Ptprca mice (Jackson) were labelled with 1 uM CellTracker Green CMFDA
(Thermo), washed, and mixed at a 1:1 ratio in PBS. 1x106 total cells were injected into
the tail veins of recipient animals. Recipients were euthanized at 1 or 24 hours after
injection. Cells from blood, spleens, and lymph nodes were harvested, stained for CD4,
CD45.1, CD45.2 and with a L/D stain (Biolegend, Tonbo), and analyzed by flow
cytometry. Input cells were analyzed in parallel. CellTracker Green was used to
distinguish between donor and recipient cells, and WT and DKO were further
distinguished by CD45.1/CD45.2 expression. Final ratios were normalized to the
corresponding input ratios.
T cell purification and culture. For functional studies, lymphoid organs were harvested
into ice cold PBS, 0.5% fatty acid free BSA, 1mM EDTA (MACS Buffer) and cell
suspensions were prepared. Naïve CD4+ T cells were harvested by negative magnetic
selection (Miltenyi), washed extensively in MACS buffer, and resuspended in DMEM
with 10% charcoal-stripped FBS (Gibco). Cells were cultured overnight at 37°C and 5%
CO2 prior to use.
S1P preparation. Sphingosine-1-Phosphate d18:1 (Avanti) powder was solubilized in
methanol:water 95:5 at 50°C with sonication. The solvent was evaporated using dry
nitrogen to create a film of S1P on the interior of the vessel, which was resuspended in
Milli-Q water supplemented with 4 mg/mL of fatty acid free BSA (Roche) to a final
concentration of 100 µM. The S1P-BSA solution was stored at -20°C in tightly-sealed
glass vials and diluted into cell culture media immediately prior to use.
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Transmigration Assays. 1x105 T cells in DMEM supplemented with 10% CS-FBS were
added into a 5-micron transwell insert (Corning) in an empty well to allow them settle for
20 minutes. The insert was gently lowered into a well containing the indicated
chemoattractant. In some experiments, the 20-minute settling phase doubled as a preincubation with 100 nM of Ex26 (Tocris). An identical concentration of the drug was
included in the lower chamber. After 90 minutes, transwell inserts were gently removed,
and the number of cells in the lower chamber were enumerated on a hemocytometer.
Microscopy. Eight well chambers (Lab-Tek #1.0 Borosilicate) were coated with 2 ug/mL
recombinant mouse VCAM-1 (R&D) overnight at 4°C and washed before use. For live
cell imaging, cells in Phenol Red-free L-15 medium (Gibco) + glucose (2 mg/mL) were
allowed to settle in the chambers for 30 minutes and then imaged by DIC microscopy at
37°C using either a 40x or 63x objective on a Zeiss Axiovert 200M inverted microscope
equipped with an MS-2000 automatic stage (Applied Scientific Instruments) and a Roper
Scientific electron-multiplying CCD camera. For experiments that include blebbistatin (5
µM s-nitro-blebbistatin, Cayman), this settling phase doubled as a pre-incubation period.
Time-lapse imaging was performed using Slidebook 6 software (Intelligent Imaging
Innovations Inc.). Cells were imaged for several minutes at which point S1P, CCL19, or
CXCL12 was dripped into the chamber, and acquisition was continued for 10 minutes.
Images were collected at 1-second intervals. For studies involving immunofluorescence
microscopy of fixed cells, cells were allowed to adhere to VCAM-coated surfaces and
stimulated with S1P. At the indicated time after addition of S1P, the media was gently
removed and the cells were fixed for 20 minutes in a solution of 10% w/v trichloroacetic
acid to preserve ERM phosphorylation [375], Cells were then permeabilized with 0.1%
Triton X-100 in PBS, blocked with PBS, 0.01% saponin, and 0.25% gelatin, stained with
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rabbit with anti-phospho ERM (CST#3141) and rat anti-tubulin (clone YL1/2) for 1 hour in
PSG, washed three times, stained with anti-rabbit AlexaFluor647 and anti-rat
AlexaFluor488 (Invitrogen), washed, and imaged using a 63x PLAN Apo 1.4 NA
objective on an Axiovert 200M (Zeiss) with a spinning disc confocal system (UltraVIEW
ERS6, Perkin Elmer) equipped with an ORCA-ER camera (Hammatsu). Image
processing was performed both using Volocity v6.3 software (Perkin Elmer) and ImageJ
(NIH). All images were prepared for publication in ImageJ.
Cell tracking. DIC chemokinesis assay movies were exported into ImageJ and cells
were tracked using the Manual Tracking plugin. For analyzing velocity (Fig. 5c), twelve
representative cells were tracked at the one-second acquisition rate, and the
instantaneous velocity was smoothed over five-second intervals before displaying. For
ease, most videos were reduced to every fifth frame prior to tracking. The different
response kinetics with S1P and chemokines forced us to analyze and track cells in each
stimulation condition differently. Following stimulation, S1P-treated cells were tracked
until the cell characteristically stopped migrating and rounded up, which generally
occurred 4-5 minutes post-stimulation (Fig. 5c). Given the slower but more sustained
chemokine response, chemokine-treated cells were tracked for 7 minutes. Due to these
differences in analysis, the different treatment conditions are graphed separately. Cells
that left the field of view, landed after stimulation, or dislodged while tracking were not
included. Dislodgement was a minor issue for S1P-treated cells, and generally only
occurred after the cell had rounded up. Dislodgement was a serious issue with CCL19
and CXCL12 treatment, affecting roughly half of the otherwise analyzable cells. We
considered this a tolerable problem since it allowed S1P and chemokine treatment to be
compared under the same experimental conditions.
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Bleb quantitation. In order for a protrusion to be classified as a bleb by DIC
microscopy, three criteria had to be met. First, the protrusion had to form rapidly,
generally in less than one second. Second, the edge of the bleb has to appear smooth
and symmetrical, which contrasts with the roughness and irregularity of actin-rich
protrusions and edges. Third, the contents of the protrusion had to be clear and devoid
of any obvious granules or organelles. These metrics were modified from Zatulovskiy et
al [152]. Once a bleb was identified, it was outlined in ImageJ and the area was
calculated. Based on the direction of migration, the bleb was then determined to have
occurred in either the rear, middle, front, or lead regions of the cell.
Immunoblotting. For experiments involving stimulation, 200 uL of cells in DMEM were
added to an Eppendorf and stimulated with 50 uL of 5x S1P (1 nM final). To stop, 1 mL
of ice-cold PBS was added, cells were rapidly centrifuged, and resuspended in lysis
buffer (50 mM Tris-HCl, 50 mM NaCl, 5 mM EDTA, 50 mM NaF, 30 mM Na4P2O7, 50
mM b-glycerophosphate, and 1% Triton X-100 in water). Cells were lysed on ice for 30
minutes with occasional vortexing then microfuged for 10 minutes. Lysates were moved
to tubes containing NuPAGE LDS sample buffer (Thermo) and boiled for 5 minutes.
Samples were then resolved on Bis-Tris 4-12% gradient gels (NuPAGE), transferred to
nitrocellulose membranes, washed with TBST, and immunoblotted overnight at 4°C in
2% BSA (w/v) TBST. The following antibodies were used for immunoblotting in this
report: Anti-ERM (Cell Signaling Technology #3142), anti-moesin (BD Biosciences clone
38, recognizes all family members), anti-phospho ERM (Cell Signaling #3141), antiGAPDH (Millipore Sigma MAB374), anti-phospho Erk1/2 Thr202/Try204 (Cell Signaling
#9101), anti-phospho Akt Ser473 (Cell Signaling #4060). Following overnight incubation,
membranes were washed multiple times with TBST and then stained with anti-rabbit or
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anti-mouse secondary antibodies conjugated to AlexaFluor680 (Thermo) or IRDye
800CW (Licor). Immunoblots were read on a Licor Odyssey imaging system and
quantified using ImageStudioLite (v. 5.2.5).
Measuring intracellular pressure (Pic). The intracellular pressure of T cells was
directly measured using the micropressure measurement technique [288]. We used a
900A micropressure system (World Precision Instruments) connected to a 0.5 μM
micropipette that is filled with a 1 M KCl solution and calibrated in a chamber with 0.1 M
KCl solution to set the overall electrical resistance of the system to zero or null. When
measuring the intracellular pressure, the tip of the micropipette is inserted through the
plasma membrane. A positive intracellular pressure pushes the electrolyte solution
further up the micropipette. The micropressure machine compensates by increasing the
pressure of an air column until a null setting is restored. This pressure value is
equivalent to the intracellular pressure. An MPC-325 micromanipulator (Sutter
Instrument) installed on an LSM700 laser scanning confocal microscope (Zeiss) was
used to position micropipette within the chamber (37°C and 10% CO2). For these
experiments, T cells were plated in chambers coated with Poly-L Lysine (Sigma) in
DMEM. Cells were left untreated (control), or stimulated with either S1P or CCL19. For
experiments using blebbistatin (50 µM), cells were pre-treated for 30-60 minutes prior to
stimulation. T cell pressure measurements were taken for 2-3 seconds and the average
pressure reading during this interval was taken as the cytoplasmic hydraulic pressure of
the cell.
Statistical analysis. All statistical tests were performed and graphs were made using
GraphPad Prism (GraphPad Software v7.0d), with specific tests indicated in figure
legends.
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